# EDGAR Filing Document

**Accession Number:** 0001412408
**File Stem:** 0001412408-26-000042
**Filing Date:** 2026-1
**Character Count:** 163827
**Document Hash:** 7ee00595db292e38efb107b3688cb1d3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001412408-26-000042.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001412408-26-000042

**CONFORMED SUBMISSION TYPE**: 8-K/A

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20251112

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260128

**DATE AS OF CHANGE**: 20260128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Phreesia, Inc.
- **CENTRAL INDEX KEY:** 0001412408
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 8-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38977
- **FILM NUMBER:** 26573777

**BUSINESS ADDRESS:**
- **STREET 1:** 1521 CONCORD PIKE
- **STREET 2:** SUITE 301 PMB 221
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19803
- **BUSINESS PHONE:** 888-654-7473

**MAIL ADDRESS:**
- **STREET 1:** 1521 CONCORD PIKE
- **STREET 2:** SUITE 301 PMB 221
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19803

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Phreesia Inc
- **DATE OF NAME CHANGE:** 20070914

?xml version='1.0' encoding='ASCII'? phr-20251112

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

___________________________________

**FORM 8-K/A**

**(Amendment No. 1)**

___________________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (date of earliest event reported)**

**November 12, 2025**

___________________________________

**Phreesia, Inc.**

(Exact name of registrant as specified in its charter)

___________________________________

---

| | | |
|:---|:---|:---|
| **Delaware**<br>**(State or other jurisdiction of incorporation or organization)** | **001-38977**<br>**(Commission File Number)** | **20-2275479**<br>**(I.R.S. Employer Identification Number)** |

---

**1521 Concord Pike, Suite 301 PMB 221**

**Wilmington, Delaware 19803**

(Address of principal executive offices and zip code)

**(888) 654-7473**

(Registrant's telephone number, including area code)

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | PHR | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

------

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Explanatory Note**

On November 12, 2025 (the "Closing Date"), Phreesia, Inc. (the "Company") filed a Current Report on Form 8-K (the "Original Report") with the U.S. Securities and Exchange Commission. The Original Report disclosed the consummation of the previously announced acquisition (the "AccessOne Acquisition") contemplated by the Agreement and Plan of Merger, dated as of August 29, 2025, by and among the Company, Ace Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company ("Merger Sub"), AccessOne Parent Holdings, Inc., a Delaware corporation ("AccessOne"), and a representative of AccessOne's equityholders, pursuant to which, upon the terms and subject to the conditions set forth therein, Merger Sub merged with and into AccessOne, with AccessOne continuing as the surviving corporation and becoming a wholly owned subsidiary of the Company.

This Amendment No. 1 to the Current Report on Form 8-K/A ("Amendment") amends the Original Report to include the historical financial statements required by Item 9.01(a) and the pro forma financial information required by Item 9.01(b) of Form 8-K, and this Amendment should be read in conjunction with the Original Report. Except as provided herein, the disclosures made in the Original Report remain unchanged, and the Company has not updated any information contained therein to reflect events that have occurred since the date of the Original Report.

The pro forma financial information included as Exhibit 99.3 to this Amendment has been presented for illustrative purposes only, as required by Form 8-K, and is not intended to, and does not purport to, represent what the combined company's actual results or financial condition would have been if the acquisition had occurred on the relevant date, and is not intended to project the future results or financial condition that the combined company may achieve following the acquisition.

**Item 9.01 Financial Statements and Exhibits.** 

(a) Financial Statements of Business Acquired

The following historical financial statements of the business acquired in the AccessOne Acquisition, attached as Exhibits 99.1 and 99.2 hereto and incorporated herein by reference:

Audited Consolidated Financial Statements of AccessOne Parent Holdings, Inc. and Subsidiaries as of and for the years ended December 31, 2024 and 2023 and the related notes; and

Interim Consolidated Financial Statements of AccessOne Parent Holdings, Inc. and Subsidiaries as of September 30, 2025 and December 31, 2024 and for the nine months ended September 30, 2025 and 2024 and the related notes.

(b) Pro Forma Financial Information

The following unaudited pro forma condensed combined financial information of the Company, giving effect to the AccessOne Acquisition and the new secured term loan entered on the Closing Date (the "Bridge Loan"), attached as Exhibit 99.3 hereto and incorporated herein by reference:

Unaudited Pro Forma Condensed Combined Balance Sheet as of October 31, 2025;

Unaudited Pro Forma Condensed Combined Statement of Operations for the nine months ended October 31, 2025 and the year ended January 31, 2025; and

Notes to the Unaudited Pro Forma Condensed Combined Financial Statements.

(d) Exhibits

------

---

| | |
|:---|:---|
| **NUMBER** | **DESCRIPTION** |
| <u>[23.1](ex231consentofcbiz.htm)</u> | <u>[Consent of CBI](ex231consentofcbiz.htm)[Z CPAs P.C](ex231consentofcbiz.htm)[.](ex231consentofcbiz.htm)[independent registered public accounting firm for AccessOne Parent Holdings, Inc.](ex231consentofcbiz.htm)</u> |
| <u>[99.1](ex991-accessone2024and2023.htm)</u> | <u>[Audited financial statements of AccessOne Parent Holdings, Inc.](ex991-accessone2024and2023.htm)[and Subsidiaries](ex991-accessone2024and2023.htm)[as of and for the years ended December 31, 2024 and 2023](ex991-accessone2024and2023.htm)</u> |
| <u>[99.2](ex992-accessoneinterimfina.htm)</u> | <u>[Unaudited financial statements of AccessOne Parent Holdings, Inc.](ex992-accessoneinterimfina.htm)[and Subsidiaries](ex992-accessoneinterimfina.htm)[as of September 30, 2025](ex992-accessoneinterimfina.htm)[and December 31, 2024](ex992-accessoneinterimfina.htm)[and for the nine months ended September 30, 2025 and 2024](ex992-accessoneinterimfina.htm)</u> |
| <u>[99.3](ex993-proformafs.htm)</u> | <u>[Unaudited pro forma condensed combined financial statements of](ex993-proformafs.htm)[Phreesia](ex993-proformafs.htm)[, Inc.as of October 31, 2025 and for the nine months ended October 31, 2025 and for the](ex993-proformafs.htm)[year ended January 31, 2025.](ex993-proformafs.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: January 28, 2026 | **Phreesia, Inc.** | **Phreesia, Inc.** |
|  | **By:** | /s/ Balaji Gandhi |
|  | **Name:** | Balaji Gandhi |
|  | **Title:** | Chief Financial Officer |

---

## Exhibit 23.1

**Exhibit 23.1**

**<u>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u>**

We consent to the incorporation by reference in the registration statements (No. 333-274387) on Form S-3ASR and registration statements (Nos. 333-285800, 333-277982, 333-273231, 333-270783, 333-264022, 333-254925, 333-237806, and 333-232832) on Form S-8 of Phreesia, Inc. of our report dated January 28, 2026, with respect to the consolidated financial statements of AccessOne Parent Holdings, Inc. and Subsidiaries for the years ended December 31, 2024 and 2023 appearing in this Current Report on Form 8-K/A dated January 28, 2026.

/s/ CBIZ CPAs P.C.

Melville, NY

January 28, 2026

## Exhibit 99.1

**Exhibit 99.1**

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONSOLIDATED FINANCIAL STATEMENTS**

**AS OF AND FOR THE YEARS ENDED** 

**DECEMBER 31, 2024 AND 2023** 

------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**TABLE OF CONTENTS**

**YEARS ENDED DECEMBER 31, 2024 AND 2023**

**CONSOLIDATED FINANCIAL STATEMENTS**

**CONSOLIDATED BALANCE SHEETS&nbsp;&nbsp;&nbsp;&nbsp;[3](#ibf330ab280964712b5498b25dc47b0e7_54)**

**CONSOLIDATED STATEMENTS OF OPERATIONS&nbsp;&nbsp;&nbsp;&nbsp;[4](#ibf330ab280964712b5498b25dc47b0e7_57)**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY&nbsp;&nbsp;&nbsp;&nbsp;[5](#ibf330ab280964712b5498b25dc47b0e7_60)**

**CONSOLIDATED STATEMENTS OF CASH FLOWS&nbsp;&nbsp;&nbsp;&nbsp;[6](#ibf330ab280964712b5498b25dc47b0e7_63)**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&nbsp;&nbsp;&nbsp;[8](#ibf330ab280964712b5498b25dc47b0e7_280)**

------

**INDEPENDENT AUDITORS' REPORT**

To the Board of Directors and Shareholders of

AccessOne Parent Holdings, Inc. and Subsidiaries

***Opinion***

We have audited the consolidated financial statements of AccessOne Parent Holdings, Inc. and Subsidiaries (the "Company"), which comprise the consolidated balance sheets as of December 31, 2024 and 2023, and the related consolidated statements of operations, changes in stockholders' equity, and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively referred to as the "financial statements").

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America.

***Basis for Opinion*** 

We conducted our audits in accordance with auditing standards generally accepted in the United States of America ("GAAS"). Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

***Responsibilities of Management for the Financial Statements*** 

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date that the financial statements are available to be issued.

***Auditors' Responsibilities for the Audit of the Financial Statements*** 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

(1) ------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Exercise professional judgment and maintain professional skepticism throughout the audit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.

/s/ CBIZ CPAs P.C.

**CBIZ CPAs P.C.** 

Melville, NY

January 28, 2026

(2) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

(In thousands, except share and per share data)

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2024** | **2023** |
| **Assets** |  |  |
| **Current:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash | $11949 | $4195 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | 77675 | 66021 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 1202 | 1380 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued interest and fees receivable, net of allowance for credit losses of $114 and $122 as of December 31, 2024 and 2023, respectively | 1052 | 1404 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred purchase price receivable | 16642 | 13923 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 1079 | 1381 |
| **Total current assets** | 109599 | 88304 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term cardholder receivables, net | 92445 | 73434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred purchase price receivable | 5012 | 3696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets, net | 1587 | 2036 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 443 | 670 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 683 | 1367 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 71964 | 71964 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred tax assets | 288 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1809 | 1474 |
| **Total Assets** | $283830 | $242945 |
| **Liabilities and Stockholders' Equity** |  |  |
| **Current:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due to health care providers | $84328 | $69528 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 436 | 820 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 3545 | 2602 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of term loan, net | 400 | 400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of lease liabilities | 533 | 572 |
| **Total current liabilities** | 89242 | 73922 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of due to health care providers | 99560 | 78711 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of lease liabilities | 1598 | 2132 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of term loan, net | 33996 | 33950 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred tax liability |  | 168 |
| **Total Liabilities** | 224396 | 188883 |
| **Commitments and contingencies (Note 15)** |  |  |
| **Stockholders' Equity:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value, 156,000 shares authorized, 30,934 and 30,905 shares issued and outstanding at December 31, 2024 and 2023, respectively |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible series A preferred stock, $0.0001 par value, 43,000 shares authorized, 39,547 shares issued and outstanding as of both December 31, 2024 and 2023 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible series B preferred stock, $0.0001 par value, 60,000 shares authorized, 51,323 shares issued and outstanding as of both December 31, 2024 and 2023 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible series C preferred stock, $0.0001 par value, 6,000 shares authorized, 5,641 shares issued and outstanding as of both December 31, 2024 and 2023 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 67720 | 67257 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (8286) | (13195) |
| **Total Stockholders' Equity** | 59434 | 54062 |
| **Total Liabilities and Stockholders' Equity** | $283830 | $242945 |

---

*See accompanying Notes to Consolidated Financial Statements.*

(3) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

(In thousands)

---

| | | |
|:---|:---|:---|
| | **For the years ended December 31,** | **For the years ended December 31,** |
| | **2024** | **2023** |
| **Revenues** | $49217 | $47799 |
| **Expenses:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenue (excluding depreciation and amortization) | 21820 | 22805 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 1697 | 4112 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 6192 | 7928 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 8108 | 6980 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 312 | 337 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | 684 | 683 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total operating expenses** | 38813 | 42845 |
| **Operating income** | 10404 | 4954 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (4913) | (4588) |
| **Income before income tax expense** | 5491 | 366 |
| **Income tax expense** | (582) | (3189) |
| **Net income (loss)** | $4909 | $(2823) |

---

*See accompanying Notes to Consolidated Financial Statements.*

(4) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**YEARS ENDED DECEMBER 31, 2024 AND 2023**

(In thousands, except share amounts)

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **Convertible** | **Convertible** | **Convertible** | **Convertible** | **Convertible** | **Convertible** | | | |
| | | | **Series A** | **Series A** | **Series B** | **Series B** | **Series C** | **Series C** | | | |
| | **Common Stock** | **Common Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | | | |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** |<br>**Additional**<br>**Paid-In**<br>**Capital** |<br>**Accumulated**<br>**Deficit** |<br>**Stockholders'**<br>**Equity** |
| **Balance December 31, 2022** | 30776 | $— | 39547 | $— | 51323 | $— | 5641 | $— | $67081 | $(10372) | $56709 |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  |  |  |  | (2823) | (2823) |
| &nbsp;&nbsp;&nbsp;Stock incentive compensation |  |  |  |  |  |  |  |  | 227 |  | 227 |
| &nbsp;&nbsp;&nbsp;Repurchase of stock options |  |  |  |  |  |  |  |  | (60) |  | (60) |
| &nbsp;&nbsp;&nbsp;Exercised stock options | 129 |  |  |  |  |  |  |  | 18 |  | 18 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital |  |  |  |  |  |  |  |  | (9) |  | (9) |
| **Balance December 31, 2023** | 30905 | $— | 39547 | $— | 51323 | $— | 5641 | $— | $67257 | $(13195) | $54062 |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  |  |  |  |  | 4909 | 4909 |
| &nbsp;&nbsp;&nbsp;Stock incentive compensation |  |  |  |  |  |  |  |  | 564 |  | 564 |
| &nbsp;&nbsp;&nbsp;Repurchase of stock options |  |  |  |  |  |  |  |  | (99) |  | (99) |
| &nbsp;&nbsp;&nbsp;Exercised stock options | 29 |  |  |  |  |  |  |  | 7 |  | 7 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital |  |  |  |  |  |  |  |  | (9) |  | (9) |
| **Balance December 31, 2024** | 30934 | $— | 39547 | $— | 51323 | $— | 5641 | $— | $67720 | $(8286) | $59434 |

---

*See accompanying Notes to Consolidated Financial Statements.*

(5) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

(In thousands)

---

| | | |
|:---|:---|:---|
| | **For the years ended<br> December 31,** | **For the years ended<br> December 31,** |
| | **2024** | **2023** |
| Net cash provided by (used in) operating activities |  |  |
| Net income (loss) | $4909 | $(2823) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 996 | 1020 |
| &nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 426 | 390 |
| &nbsp;&nbsp;&nbsp;Non-cash operating lease expense | 449 | 535 |
| &nbsp;&nbsp;&nbsp;Stock incentive compensation | 564 | 227 |
| &nbsp;&nbsp;&nbsp;Accrued interest on stock purchase receivable | (9) | (9) |
| &nbsp;&nbsp;&nbsp;Deferred taxes | (521) | 1554 |
| &nbsp;&nbsp;&nbsp;Other cash provided by (used for) securitization program | 7143 | (1605) |
| Changes in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 178 | 51 |
| &nbsp;&nbsp;&nbsp;Accrued interest receivable | 352 | 73 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | 302 | (589) |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 640 | 547 |
| &nbsp;&nbsp;&nbsp;Lease liabilities | (573) | (647) |
| Net cash provided by (used in) operating activities | 14856 | (1276) |
| Cash flows from investing activities |  |  |
| &nbsp;&nbsp;&nbsp;Collections of DPP receivable | 17310 | 4657 |
| &nbsp;&nbsp;&nbsp;Collections of unfunded cardholder receivables | 97054 | 107640 |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (53) | (52) |
| Net cash provided by investing activities | 114311 | 112245 |
| Cash flows from financing activities |  |  |
| &nbsp;&nbsp;&nbsp;Repurchase of stock options | (99) | (60) |
| &nbsp;&nbsp;&nbsp;Capitalization of debt issuance costs | (16) | (91) |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock | 7 | 18 |
| &nbsp;&nbsp;&nbsp;Payments of due to health care providers for unfunded receivables | (120724) | (111257) |
| &nbsp;&nbsp;&nbsp;Payments on term loan | (363) | (464) |
| Net cash used in financing activities | (121195) | (111854) |
| Net increase (decrease) in cash and restricted cash | 7972 | (885) |
| Cash and restricted cash - beginning of year | 5668 | 6553 |
| Cash and restricted cash - end of year | $13640 | $5668 |
| **SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $4521 | $4182 |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes | $1200 | $794 |
| **RECONCILIATION OF CASH AND RESTRICTED CASH SHOWN IN STATEMENTS OF CASH FLOWS** | **RECONCILIATION OF CASH AND RESTRICTED CASH SHOWN IN STATEMENTS OF CASH FLOWS** |  |
| &nbsp;&nbsp;&nbsp;Cash per balance sheets | $11949 | $4195 |
| &nbsp;&nbsp;&nbsp;Restricted cash included in long-term other assets | 1691 | 1473 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cash and restricted cash shown in statements of cash flows | $13640 | $5668 |

---

*See accompanying Notes to Consolidated Financial Statements.*

(6) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

(In thousands)

---

| | | |
|:---|:---|:---|
| **NON-CASH INVESTING AND FINANCING ACTIVITIES** | | |
| Noncash activity related to cardholder receivables and deferred purchase price | $139239 | $155890 |

---

*See accompanying Notes to Consolidated Financial Statements.*

(7) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

**NOTE 1ORGANIZATION AND NATURE OF OPERATIONS**

AccessOne Parent Holdings, Inc. (AccessOne Parent Holdings), a Delaware Corporation formed in November 2021 headquartered in Fort Mill, South Carolina, is the parent company of its wholly owned subsidiary, AccessOne Holdings, Inc (Holdings). Holdings is a holding company of its wholly owned operating entities, AccessOne MedCard, Inc. (AccessOne MedCard) and CueSquared, Inc. (CueSquared). AccessOne Funding, LLC (AccessOne Funding) is a wholly owned subsidiary of AccessOne MedCard (collectively the Company).

AccessOne MedCard is a leading technology-enabled financial services corporation that helps patients manage their out-of-pocket health care costs while offering health care providers a comprehensive, compliant, and patient-friendly solution for improving access to care and collection of self-pay patient receivables on a recourse basis. CueSquared offers a cloud-based direct mobile payment platform and analytics dashboard for health care providers.

The Company principally derives its revenues from finance charges on cardholder receivables, servicing fees earned for administering self-pay patient accounts on behalf of health care providers, and fees generated through the Company's direct mobile payment (DMP) platform. Additional revenues include late fees and other service charges assessed on patient accounts. These revenue streams are generated through the Company's technology-enabled payment solutions, which facilitate patient financing and enhance provider collections.

**NOTE 2SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**<u>Principles of Consolidation</u>**

The accompanying consolidated financial statements include the accounts and activity of AccessOne Parent Holdings, its wholly owned subsidiary, AccessOne Holdings and its wholly owned subsidiaries, AccessOne MedCard and CueSquared, and AccessOne Funding, a wholly owned subsidiary of AccessOne MedCard. All significant intercompany transactions and balances are eliminated. AccessOne Funding is a special-purpose entity (SPE) and variable interest entity (VIE) for which the Company is the primary beneficiary.

**<u>Basis of Presentation</u>**

The Company's consolidated financial statements are prepared under the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP).

**<u>Use of Estimates</u>**

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Material estimates that are particularly susceptible to significant change in the near-term include the valuation of stock-based compensation, the valuation of reporting units for the purpose of testing goodwill for impairment, the valuation of long-lived assets and their recoverability, and the valuation of

(8) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

deferred tax assets and liabilities and other tax estimates including the ability to utilize net operating losses.

**<u>Concentration of Credit Risk</u>**

Substantially all cash is deposited in one financial institution. At times, amounts on deposit may be in excess of the Federal Deposit Insurance Corporation (FDIC) insurance limit.

For the years ended December 31, 2024 and 2023, the Company derived approximately 61% and 59%, respectively, of its revenue from three health care providers and the patients of those providers.

As of December 31, 2024 and 2023, approximately 83% and 80%, respectively, of the Company's outstanding cardholder receivables were from patients of two health care providers.

The loss of one of these health care providers as a customer could have a significant impact on the Company's financial position, results of operations, and cash flows.

**<u>Variable Interest Entities</u>**

Pursuant to GAAP, a VIE is an entity that either (i) has insufficient equity to permit the entity to finance its activities without additional subordinated financial support or (ii) has equity investors who lack the characteristics of a controlling financial interest. A VIE is consolidated by its primary beneficiary. The primary beneficiary has both the power to direct the activities that most significantly impact the entity's economic performance and the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the VIE. If the Company determines that it has operating power and the obligation to absorb losses or receive benefits, it will consolidate the VIE as the primary beneficiary, and if not, it does not consolidate.

**<u>Revenue Recognition</u>**

The Company follows Financial Accounting Standards Board Accounting Standards Codification (ASC) Topic 606, *Revenue from Contracts with Customers* (Topic 606) to record revenue certain of its revenue streams. The guidance requires that an entity follow a five-step model to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. Topic 606 covers all revenue streams except those covered by other standards.

The Company follows ASC Topic 606 to record revenue for Direct Mobile Payment (DMP) fees. Customers who use the mobile patient payment platform are billed monthly based on variable usage of the platform or minimum contractual billings. DMP notification fee revenue is not significant and is included in other revenues in the table below.

The Company follows ASC Topic 860, *Transfers and Servicing,* to record revenue for cardholder servicing fees. The Company services cardholder receivables on behalf of health care providers and servicing fee income is recognized as the services are performed. The Company evaluates whether servicing fees represent adequate compensation and whether a servicing asset or servicing liability should be recorded. The Company has determined that servicing fees approximate adequate compensation; therefore, no servicing asset or liability is recognized.

The Company follows ASC Topic 310, *Receivables,* to record revenue for finance charges earned on cardholder receivables. Finance charges are recognized using a method that approximates the effective interest method over the contractual term of the receivable. Accrual of finance charges ceases

(9) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

when an account becomes 90 days past due, and previously accrued but unpaid interest is reversed. Accrual resumes when the receivable returns to current status.

The following table sets forth the significant components of the Company's revenues for the years ended December 31, 2024 and 2023, respectively:

---

| | | |
|:---|:---|:---|
| | **For the years ended December 31** | **For the years ended December 31** |
| | **2024** | **2023** |
| **Revenue:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder servicing fees | $26894 | $22703 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finance charges | 13321 | 17475 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other revenues | 9002 | 7621 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total revenues** | $49217 | $47799 |

---

**<u>Cash and Restricted Cash</u>**

For purposes of the consolidated statements of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. Substantially all cash is deposited in one financial institution.

For the years ended December 31, 2024 and 2023, the Company was required to maintain $5,000 of liquidity, which includes unrestricted cash and availability under its credit and securitization agreements. The Company was in compliance with these requirements as of December 31, 2024 and 2023.

<u>Restricted Cash</u>

As a part of the *Cardholder Receivables Securitization Program* disclosed within Note 5, the Company is required to maintain a cash reserve account equal to 1% of the outstanding credit card receivables in the securitization. The restricted cash balance is legally segregated and not available for general corporate purposes. Restricted cash was $1,691 and $1,473 as of December 31, 2024 and 2023, respectively, and is included in other assets on the consolidated balance sheets.

**<u>Cardholder Receivables, Net</u>**

The Company's cardholder receivables consist of self-pay patient accounts purchased from health care provider partners. Cardholder receivables are reported at their unpaid principal balances adjusted for deferred fees on originated balances. Patient repayment terms require monthly payments based on revolving credit schedules. Cardholder receivables have an estimated average contractual maturity of 15 months. The Company is responsible for billing, collecting, and remitting the amount equal to the principal payment, less a service fee, to the health care provider.

Interest income is accrued on the unpaid principal balance. The accrual of interest is discontinued at the time the loan is 90 days past due. Past due status is based on contractual terms of the cardholder receivable. Client origination fees are deferred and recognized as an adjustment of the related yield on a straight-line basis that approximates the effective interest method. All interest accrued but not collected is reversed against interest income and amortization of related deferred fees or costs is suspended.

The Company has full recourse against the health care providers for unpaid principal. If, at any point in time, the patient fails to make three consecutive minimum monthly payments, the unpaid balance is

(10) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

repurchased by the health care provider. At December 31, 2024 and 2023, the Company determined an allowance for credit losses for these receivables was not required due to these full recourse provisions.

**<u>Accounts Receivable</u>**

Customers who use the mobile patient payment platform provided by CueSquared are billed monthly based on variable usage of the platform or minimum contractual billings resulting in accounts receivables. The receivables of the Company also include amounts related to fees and charges that have been billed to patient accounts.

The allowance for credit losses on receivables is a valuation account that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected. The allowance for credit losses is adjusted through the provision for credit losses. Losses are charged off against the allowance for credit losses when the Company determines the balance to be uncollectible. Cash received on previously charged off amounts is recorded as a recovery to the allowance for credit losses.

The measurement of expected credit losses encompasses information about historical events, current conditions, and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. Qualitative adjustments to historical loss information are made for differences in current specific risk characteristics such as delinquency, as well as for changes in environmental conditions.

The Company uses an aging method to estimate credit losses. The aging method pools receivables based on levels of delinquency and applies historical loss rates, adjusted for current conditions and reasonable and supportable forecasts, to each pool.

At December 31, 2024 and 2023, management determined an allowance for credit losses was not necessary.

**<u>Prepaid Expenses and Other Assets</u>**

Prepaid expenses and other assets include amounts paid to third parties in advance for insurance, postage, marketing events, and other services. These amounts are expensed as the underlying services are provided or when events are attended.

**<u>Leases</u>**

The Company determines if an arrangement is a lease at inception. Operating and finance leases are reported as right-of-use (ROU) assets, net and lease liabilities on the consolidated financial statements.

ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company has elected to recognize payments for short-term leases with a lease term of 12 months or less as expense as incurred and these leases are not included as lease liabilities or right-of-use assets on the consolidated balance sheets.

(11) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

The Company has elected not to separate nonlease components from lease components and instead accounts for each separate lease component and the nonlease component as a single lease component.

ROU assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets.

The Company subleases certain of its leased assets. The head lease and any sublease are accounted for as separate contracts. Sublease income is recognized on a straight-line basis over the sublease term and presented separately from lease expense in the consolidated statements of operations.

**<u>Property and Equipment, Net</u>**

Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Major additions and improvements are capitalized, while replacements, maintenance, and repairs, which do not improve or extend the life of the respective assets, are expensed as incurred. Depreciation and amortization of property and equipment is computed using the straight-line method over the estimated useful lives of the assets as follows:

---

| | |
|:---|:---|
| Computer equipment | 3 Years |
| Software | 3 Years |
| Furniture and fixtures | 7 Years |
| Leasehold improvements | Lease Term |

---

Leasehold improvements are depreciated over the lease term as it is shorter than the useful life.

**<u>Internal Use Software</u>**

Capitalized software costs, included by the Company as a component of property and equipment, may consist of costs to purchase software to be used within the Company and costs to develop software internally. Capitalization of purchased or internally developed software that is not licensed to customers occurs after the preliminary stage and during the actual application development stage. Capitalization ends when the project is complete and placed in service. Upgrades and enhancements that result in additional functionality are also capitalized. Management determined that no software costs met the criteria for capitalization during the years ended December 31, 2024 and 2023.

**<u>Intangible Assets, Net</u>**

Intangible assets acquired through a business combination or asset purchase agreement are recorded at fair value when acquired while intangible assets acquired through operations are recorded at cost when acquired. Intangible assets are stated at cost, less accumulated amortization. Intangible assets are reviewed for impairment consistent with long-lived assets.

The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives as follows:

---

| | |
|:---|:---|
| Developed technology | 3 Years |
| Tradename | 3 Years |
| Customer relationships | 3 Years |

---

(12) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

**<u>Goodwill</u>**

Goodwill arises from business combinations and is determined as the excess of the fair value of the consideration transferred over the fair value of the net assets acquired and liabilities assumed as of the acquisition date. Goodwill and intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but tested for impairment annually, or more frequently if events and conditions exits that indicate that a goodwill impairment should be performed. The Company first assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that the fair value of a reporting unit is less than its carrying amount, including goodwill.

Significant judgment is applied when goodwill is quantitatively assessed for impairment. This judgment includes developing cash flow projections, selecting appropriate discount rates, identifying relevant market comparables, incorporating general economic and market conditions, and selecting an appropriate control premium.

During the years ended December 31, 2024 and 2023, the Company did not record any impairments of its goodwill.

**<u>Long-Lived Assets</u>**

Long-lived assets such as property and equipment and intangible assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when estimated future undiscounted cash flows expected to result from the use of the assets and their eventual disposition is less than their carrying amount. During the years ended December 31, 2024 and 2023, the Company did not record any impairments of intangible assets.

**<u>Due to Health Care Providers</u>**

Due to health care providers represents a recourse liability for cardholder receivable accounts which have been purchased by the Company. The recourse liability is repaid as cardholder receivables are settled or repurchased by the heath care provider.

**<u>Debt Issuance Costs</u>**

The Company presents debt issuance costs as a direct deduction from the face amount of the related borrowings, amortizes debt issuance costs using the effective interest method over the life of the debt, and records the amortization as a component of interest expense.

**<u>Servicing</u>**

The Company services cardholder receivables for health care providers that are not included in the accompanying consolidated balance sheets. The unpaid principal balance of cardholder receivables serviced for others was approximately $113,179 and $107,978 as of December 31, 2024 and 2023, respectively. Management has not recorded an asset or liability for cardholder receivables serviced for others as compensation reflects market rate and a typical servicer's cost to service. The serviced receivables are also short-term in nature. The Company recognizes servicing fee income assessed on the payment balances collected.

**<u>Transfers of Financial Assets</u>**

Transfers of an entire financial asset or a participating interest in an entire financial asset are accounted for as sales when control over the assets has been surrendered. Control over transferred assets is

(13) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

deemed to be surrendered when (1) the assets have been isolated from the Company, (2) the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets, and (3) the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity.

**<u>Income Taxes</u>**

The Company utilizes an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for differences between the consolidated financial statements and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.

The Company adheres to the income tax standard for uncertain tax positions. The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The Company evaluated its tax positions and determined it has no uncertain tax positions as of December 31, 2024 and 2023.

**<u>Stock Compensation Plans</u>**

Stock compensation accounting guidance requires that the compensation cost relating to share-based payment transactions be recognized in the consolidated financial statements. The cost will be measured based on the grant date fair value of the equity or liability instruments issued. The stock compensation accounting guidance covers a wide range of share-based compensation arrangements including stock options, restricted share plans, performance-based awards, share appreciation rights, and employee share purchase plans.

The stock compensation accounting guidance requires that compensation cost for all stock awards be calculated and recognized over the employee's service period, generally defined as the vesting period. For awards with graded-vesting, compensation cost is recognized on a straight-line basis over the requisite service period for the entire award. Certain option awards include vesting conditions based on the achievement of specified operational or financial performance metrics. Compensation expense for awards with performance conditions is recognized only when achievement of the performance condition is considered probable. The Company evaluates the probability of achieving performance conditions at each reporting date. A Black-Scholes model is used to estimate fair value of stock options, while the market price of the Company's common stock at the date of grant is used for restricted stock awards. The Company adjusts stock compensation expense for forfeitures of stock-based compensation awards in the periods the forfeitures occur.

**<u>Stock Purchase Receivable</u>**

The Company is the holder of an interest-bearing promissory note receivable from a stockholder in lieu of a cash payment for the purchase of common stock. Pursuant to ASC 505-10, *Equity*, management classifies stock purchase receivables as a component of equity (offset to the stock issued) when the Company receives a note in exchange for common stock unless there is substantial evidence supporting intent and ability to pay the note in a reasonably short period of time.

**<u>Advertising Costs</u>**

(14) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

Advertising costs are expensed as incurred and are reported in general and administrative expense on the consolidated statements of operations. Advertising costs were insignificant for the years ended December 31, 2024 and 2023.

**<u>Fair value of Financial Instruments</u>**

Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for the sale of an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are required to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.

Level 3—Unobservable inputs which are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The carrying value of the Company's short-term financial instruments, including accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. As of December 31, 2024, the carrying value of the Company's debt approximated fair value because the interest rates approximated market rates.

The Company did not have any transfers of assets and liabilities between levels of the fair value measurement hierarchy during both the years ended December 31, 2024 and 2023.

**<u>Subsequent Events</u>**

In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through January 28, 2026, the date the consolidated financial statements were issued. See Note 16.

**NOTE 3CARDHOLDER RECEIVABLES, NET**

The Company has a portfolio of cardholder receivables that consist of the following as of December 31, 2024 and 2023:

(15) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

---

| | | |
|:---|:---|:---|
| Short-term cardholder receivables | Short-term cardholder receivables | Short-term cardholder receivables |
|  | 2024 | 2023 |
| Short-term cardholder receivables | $83469 | $70840 |
| Deferred origination fees | (5794) | (4819) |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | $77675 | $66021 |
| Long-term cardholder receivables | Long-term cardholder receivables | Long-term cardholder receivables |
|  | 2024 | 2023 |
| Long-term cardholder receivables | $99340 | $78794 |
| Deferred origination fees | (6895) | (5360) |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | $92445 | $73434 |
| Total cardholder receivables | Total cardholder receivables | Total cardholder receivables |
|  | 2024 | 2023 |
| Cardholder receivables | $182809 | $149634 |
| Deferred origination fees | (12689) | (10179) |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | $170120 | $139455 |

---

The Company elected to exclude accrued interest receivable from the amortized cost basis of cardholder receivables.

As described in Note 2, all cardholder receivables are subject to a recourse agreement with the respective selling health care provider and no allowance for credit loss is required.

After 90 days of non-payment, cardholder receivables are returned to the provider and the related due to provider liability is extinguished. Accordingly, all outstanding cardholder receivables are aged less than 90 days.

**NOTE 4ACCOUNTS RECEIVABLE**

The following summarizes the components of accounts receivable at December 31, 2024 and 2023:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Accounts receivable | $1202 | $1380 |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable, net | $1202 | $1380 |

---

(16) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

At December 31, 2024 and 2023, management determined an allowance for credit losses was not necessary.

**NOTE 5CARDHOLDER RECEIVABLE SECURITIZATION PROGRAM**

The Company has a securitization program to sell cardholder receivables to PNC Bank (PNC). Once sold to PNC, the Company has no retained interests in the cardholder receivables and the cardholder receivables sold are derecognized from the Company's consolidated balance sheets.

Under the program, AccessOne MedCard sells cardholder receivables to AccessOne Funding, a special-purpose entity (SPE), for an amount equal to their face value. The SPE is a VIE for which AccessOne Holdings is the primary beneficiary. The SPE's sole business consists of the purchase of receivables from AccessOne MedCard and the subsequent sale of cardholder receivables to PNC. Although the SPE is included in the Company's consolidated financial statements, it is a separate legal entity with separate creditors. AccessOne Funding then sells the cardholder receivables to PNC for an initial cash purchase price (equal to the nominal amount of such receivables) and the right to receive a deferred purchase price (DPP).

The DPP reflects the portion of the purchase price for the cardholder receivables which is not paid in cash. It is a beneficial interest in the sold cardholder receivables and is recognized as part of the sale transaction. The DPP functions as a credit enhancement and is settled from collections of securitized cardholder receivables by the Company. Repayment of the DPP is conditional on the performance of the securitized cardholder receivables.

The cardholder securitization program has a maturity date, after amendments, of February 3, 2026. This program can be renewed with consent from the parties.

The following table summarizes the sold cardholder receivables outstanding balance, net of DPP asset, under the outstanding securitization program as of and for the years ended December 31, 2024 and 2023:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Sold receivables at the beginning of the year | $167354 | $174848 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sale of cardholder receivables | 183763 | 157152 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash collections (remitted to PNC) | (163428) | (164646) |
| Sold receivables at the end of the year | $187689 | $167354 |

---

The Company incurs securitization-related costs including deferred costs. Securitization-related costs of $10,668 and $10,717 were included in cost of revenue (excluding depreciation and amortization) in the consolidated statements of operations for the years ended December 31, 2024 and 2023, respectively.

Eligible costs are capitalized and amortized over the term of program. The unamortized balance of the capitalized securitization costs at December 31, 2024 and 2023 was approximately $476 and $827, and is reported in prepaid expenses and other assets on the consolidated balance sheets. The Company included $351 and $604 of expense within cost of revenue (excluding depreciation and amortization) on the consolidated statements of operations for the years ended December 31, 2024 and 2023, respectively.

(17) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

**NOTE 6PROPERTY AND EQUIPMENT, NET**

Property and equipment consisted of the following as of December 31, 2024 and 2023:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Computer equipment | $943 | $859 |
| Software | 1787 | 1787 |
| Leasehold improvements | 1062 | 1073 |
| Furniture and fixtures | 345 | 379 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 4137 | 4098 |
| Less: Accumulated depreciation | (3694) | (3428) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | $443 | $670 |

---

Depreciation expense for the years ended December 31, 2024 and 2023 was approximately $312 and $337, respectively.

**NOTE 7INTANGIBLE ASSETS AND GOODWILL**

The Company assesses both goodwill and intangible assets for impairment annually as of December 31 or more frequently if events or changes in circumstances indicate the asset might be impaired.

The Company did not record any goodwill impairments during the years ended December 31, 2024 or 2023.

Following is a summary of intangible assets:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Developed technology | $500 | $500 |
| Acquired customer relationships | 1400 | 1400 |
| Tradename | 150 | 150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 2050 | 2050 |
| Less: Accumulated amortization of developed technology and acquired customer relationships | (1367) | (683) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total intangible assets, net | $683 | $1367 |

---

Amortization expense for the years ended December 31, 2024 and 2023 was approximately $684 and $683, respectively.

Estimated future amortization expense for intangible assets is as follows:

---

| | |
|:---|:---|
| <u>Year ending December 31,</u> | Amount |
| 2025 | $683 |
| Total | $683 |

---

As of December 31, 2024, the weighted-average remaining amortization period was 1 year.

(18) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

**NOTE 8REVOLVING LOAN, NET**

The Company has a revolving credit agreement with PNC (PNC Agreement) providing for maximum available borrowing capacity on revolving loans of $2,500, including a letter of credit subfacility as of December 31, 2024 and 2023. Amounts borrowed under the PNC Agreement may be repaid and re-borrowed at any time prior to the maturity date of December 31, 2025, at which time all principal and interest are due. The revolving loans are collateralized by all assets of the Company.

The revolving commitment provides for both Secured Overnight Financing Rate (SOFR) and Base Rate loans, and the loan type dictates the interest rate charged on the balance outstanding. Loans may be converted from a SOFR loan to a base rate loan at any time.

Interest on the revolving line of credit is charged monthly, on a variable rate basis, at the rate per annum equal to the daily simple SOFR plus a margin of 4.00% for SOFR loans, or the greater of the Overnight Bank Funding Rate plus 0.5%, or *WSJ* Prime Rate, or the daily simple SOFR plus 1.00%, plus a margin of 3.00% for Base Rate loans. All loans are subject to an interest rate floor of 0.50%.

The daily simple SOFR is published by the Federal Reserve Bank of New York (4.49% at December 31, 2024) and is subject to adjustments as defined in the agreement, depending on the date the SOFR is computed and the SOFR reserve percentage.The PNC Agreement includes an unused line fee (0.60% at December 31, 2024) of the difference between the commitment and the average daily balance of the revolving loans.

There was no balance outstanding on the PNC Agreement as of December 31, 2024 and 2023.

The PNC Agreement subjects the Company to certain financial and nonfinancial covenants. As of December 31, 2024, the Company was in compliance with the respective financial and nonfinancial covenants.

**NOTE 9TERM LOAN, NET**

The Company entered into a credit agreement with CCP Agency, LLC (the Comvest loan) for $40,000. Following the initial funds, the Company may request additional term loans (incremental term loans) not to exceed $50,000 in the aggregate.

The revolving commitment provides for both SOFR and Base Rate loans, and the loan type dictates the interest rate charged on the balance outstanding. Loans may be converted from a SOFR loan to a base rate loan at any time.

Interest on the borrowed funds is charged monthly, on a variable basis, at the rate per annum equal to the SOFR plus the applicable margin as defined in the agreement, for SOFR loans, or at the rate per annum equal to the Base Rate plus the applicable margin as defined in the agreement, for Base Rate loans.

The SOFR is published by the Federal Reserve Bank of New York (4.49% and 5.38% at December 31, 2024 and 2023, respectively) and is subject to adjustments as defined in the agreement.

(19) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

As of December 31, 2024 and 2023, the loan was a SOFR loan and was assessed interest at 10.67% and 12.95% per annum, respectively.

The Company incurred debt issuance costs which are amortized over the term of the loan. Amortization expense totaled approximately $426 and $390 and was reported as interest expense on the consolidated statements of operations for the years ended December 31, 2024 and 2023, respectively.

The loan includes financial covenants including, but not limited to, requiring the Company to maintain minimum liquidity, a minimum Fixed Charge Coverage ratio, a maximum Senior Leverage Ratio, and a maximum Percentage of Recourse Put-Backs. The Company was in compliance with all covenants related to the Credit Agreement as of December 31, 2024.

The balance of term loan, net consisted of the following at December 31:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Current portion of term loan | $408 | $413 |
| Unamortized debt issuance costs | (8) | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term loan, net | $400 | $400 |
| Long-term portion of term loan | $34665 | $35024 |
| Unamortized debt issuance costs | (669) | (1074) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of term loan, net | $33996 | $33950 |

---

Beginning September 30, 2021, and on the last day of each fiscal quarter to occur thereafter, the Company must repay $100 of the initial term loan as well as 0.25% of the original principal amount of each such incremental term loan advance. The loan matures on August 20, 2026, at which point the remaining outstanding principal amount of the initial term loan and any incremental term loan advance is due.

Maturities of the term loan, net are as follows at December 31, 2024:

---

| | |
|:---|:---|
| <u>Year ending December 31,</u> |  |
| 2025 | $400 |
| 2026 | 34673 |
| Total | $35073 |

---

As of December 31, 2024 and 2023, the fair value of debt approximated its unpaid principal amount.

**NOTE 10STOCKHOLDERS' EQUITY**

**<u>Common Stock</u>**

Each holder of Common Stock shall be entitled to one vote equal to the number of shares held.

**<u>Series A Preferred Stock</u>**

(20) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

Each holder of outstanding shares of Series A Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series A Preferred Stock are convertible. Except as provided for in the certificate of incorporation, holders of preferred stock shall vote together with the holders of Common Stock as a single class on an as-converted basis. Each Series A Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable Common Shares as is determined by dividing the Series A Preferred Original Issue Price by the Preferred A Conversion price (as defined in the most recent Certificate of Incorporation) at the time of conversion. Series A Preferred Stock does not contain any redemption rights or redemption clauses.

**<u>Series B Preferred Stock</u>**

On May 11, 2018, Holdings issued 54,091 shares of $.0001 par value Series B Preferred Stock at $481.67 per share for an aggregate investment of $26,05.

Each holder of outstanding shares of Series B Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series B Preferred Stock are convertible. Except as provided for in the certificate of incorporation, holders of preferred stock shall vote together with the holders of Common Stock as a single class on an as-converted basis.

Each Series B Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable Common Shares as is determined by dividing the Series B Preferred Original Issue Price by the Preferred B Conversion price (as defined in the most recent Certificate of Incorporation) at the time of conversion. Series B Preferred Stock does not contain any redemption rights or redemption clauses.

**<u>Series C Preferred Stock</u>**

On December 14, 2021, the Company issued 5,641 shares of $0.0001 par value Series C Preferred Stock at $1,063.71 per share for an aggregate equity investment of $6,000.

Each holder of outstanding shares of Series C Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series C Preferred Stock are convertible. Except as provided for in the certificate of incorporation, holders of preferred stock shall vote together with the holders of Common Stock as a single class on an as-converted basis.

Each Series C Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable Common Shares as is determined by dividing the Series C Preferred Original Issue Price by the Preferred C Conversion price (as defined in the most recent Certificate of Incorporation) at the time of conversion. Series C Preferred Stock does not contain any redemption rights or redemption clauses.

**<u>Dividends</u>**

(21) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

The Company shall not declare, pay, or set aside any dividends on the Common Stock unless the holders of Series A Preferred Stock, Series B Preferred Stock first and Series C Preferred Stock (collectively, the Preferred Stockholders) receive, or simultaneously receive, a dividend on each outstanding preferred share in an amount at least equal to that dividend per preferred share as would be received upon conversion to Common Stock.

**<u>Liquidation Preference</u>**

Upon any liquidation, dissolution, or winding up of the Company, the holders of Series A Preferred Stock are entitled to a distribution in an amount equal to the original purchase price of their shares totaling approximately $19,048.

Second, after payment of the original purchase price to Series A Preferred Stockholders, the holders of Series B Preferred Stock are entitled to a distribution in an amount equal to 80.90% of the original purchase price of their shares totaling approximately $19,999.

Third, after payment of the original purchase price to Series A Preferred Stockholders and 80.90% of the original purchase price to Series B Preferred Stock, the holders of Series C Preferred Stock are entitled to a distribution in an amount equal to the original purchase price of their shares totaling approximately $6,000.

If upon any liquidation, dissolution, or winding up of the Company, the distributable assets are not sufficient to pay in full the aforementioned preferred liquidation amounts for all Preferred Stockholders, the entire distributable assets shall be distributed proportionately to all Preferred Stockholders.

Third, after payment to Preferred Stockholders, all remaining distributable assets shall be distributed among the holders of Preferred Stock and Common Stockholders on a ratable basis, based on number of shares held by each such holder as if Preferred Stock had been converted to Common Stock immediately prior to such liquidation event.

Lastly, if a liquidation event results in the Preferred Stockholders being entitled to receive an amount in excess of three times the original purchase, each Preferred Stockholder shall also be entitled to receive the greater of (1) three times the original purchase price and (2) the amount such holder would have received if all Series A Preferred Stock had been converted into shares of Common Stock immediately prior to such liquidation event.

**<u>Warrants to Purchase Common Stock</u>**

The Company previously issued 7,030 warrants to purchase Common Stock in connection with a previous promissory note, which are outstanding and unexercised at December 31, 2024. The warrants were valued and considered fully vested on the date of issuance during 2017 and may be exercised in whole or in part, at any time, and from time to time until fully exercised, at the election of the holder at an exercise price of $1.00.

The warrants expire at the earlier of the (a) tenth anniversary of the grant date on March 2, 2027, (b) liquidation event, and/or (c) immediately prior to the closing of a firm commitment underwritten initial public offering pursuant to an effective registration statement filed under the Securities Act covering the offering and sale of the Company's Common Stock.

**NOTE 11STOCK INCENTIVE PLAN**

(22) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

The AccessOne Holdings, Inc. Stock Incentive Plan (the Plan) permits the Company to grant to employees, directors, and contractors Common Stock options (Awarded Options). A maximum of 17,739 shares of Common Stock were reserved to be granted under the Plan as of December 31, 2024. After the formation of AccessOne Parent Holdings, the Plan and previously awarded options were transferred to the new entity.

A summary of the Plan's activity is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Options | Options | | |
| | Available | Outstanding |<br>Weighted<br>Average<br>Exercise<br>Price | Weighted<br>Average<br>Remaining<br>Contractual<br>Term |
| Balance - December 31, 2022 | 5177 | 12562 | $486.35 | 4.2 |
| &nbsp;&nbsp;Granted | (900) | 900 | 750.00 |  |
| &nbsp;&nbsp;Exercised | 129 | (129) | 139.13 |  |
| &nbsp;&nbsp;Cancelled | 1882 | (1882) | 649.93 |  |
| Balance - December 31, 2023 | 6288 | 11451 | 476.28 | 2.7 |
| &nbsp;&nbsp;Granted | (3200) | 3200 | 272.10 |  |
| &nbsp;&nbsp;Exercised | 29 | (29) | 254.68 |  |
| &nbsp;&nbsp;Cancelled | 1846 | (1846) | 734.08 |  |
| Balance - December 31, 2024 | 4963 | 12776 | $215.09 | 1.7 |
| Exercisable - December 31, 2024 |  | 7710 | $215.09 | 1.7 |

---

During the year ended December 31, 2024, the Company modified the exercise price for 20 employees' options granted between 2021 and 2023. The modification, which reduced the exercise price to $272.10, resulted in approximately $146 in additional compensation expense during the year ended December 31, 2024. The Company anticipates recognizing an additional $66 in compensation expense from the modification between 2025 and 2027.

The awarded options generally vest over a two-year to four-year period of service with the Company or upon meeting certain performance metrics, as defined. The Company recognized stock incentive compensation expense of approximately $564 and $227 for the years ended December 31, 2024 and 2023, respectively.

The awarded options are subject to forfeiture until vested. If employment is terminated before vesting occurs, whether voluntarily or involuntarily, the awarded options shall be forfeited immediately. Any awarded options vested at the time of termination shall continue to be subject to such restrictions as may apply under the terms of the Plan, and individual award agreement and/or the 2016 Stock Incentive Plan agreement as amended through September 19, 2022. The Company has the right to repurchase vested options from option holders upon separation from the Company.

(23) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

The weighted-average fair value of options granted and the weighted-average assumptions utilized in the Black-Scholes option-pricing model are noted in the following table:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Weighted-average fair value of options granted | $272.10 | $295.88 |
| Risk free interest rate | 4.48% | 3.88% |
| Expected term (in years) | 7 | 7 |
| Expected volatility | 45% | 40% |
| Dividend yield | —% | —% |

---

The Company calculates its volatility index based on the Company's trending average over the expected term of the option. The risk-free interest rates for periods within the expected term of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected term of Awarded Options granted represents the weighted average period that the stock options are expected to remain outstanding. The Company does not have sufficient historical exercise data. Accordingly, the expected term of stock options was estimated using the simplified method, which calculates expected term as the midpoint between the vesting period and the contractual term. The Company currently has no history or expectation of paying cash dividends on its Common Stock.

At December 31, 2024, the Company had unrecognized stock option expense of approximately $496 that will be recognized ratably through 2028.

**NOTE 12LEASES**

The Company leases office spaces under operating lease agreements that expire at various dates through 2028. The following tables provides quantitative information concerning the Company's leases for the year ended December 31:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Lease costs<sup>(1)</sup>: |  |  |
| &nbsp;&nbsp;Operating lease cost | $628 | $806 |
| &nbsp;&nbsp;Finance lease cost | 12 | 12 |

---

---

| | | |
|:---|:---|:---|
| Other information: |  |  |
| &nbsp;&nbsp;Weighted-average remaining lease term: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 3.4 Years | 4.3 Years |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 2.4 Years | 3.4 Years |
| &nbsp;&nbsp;Weighted-average discount rate: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 7.66% | 7.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 7.66% | 7.66% |

---

<sup>(1)</sup> Variable lease cost and short-term lease cost are not significant.

Other supplemental cash flow information related to operating leases for the years ended December 31 is as follows:

(24) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;Operating cash flows from operating leases | $751 | $918 |
| &nbsp;&nbsp;ROU assets obtained in exchange for new operating lease liabilities |  |  |

---

A maturity analysis of annual discounted cash flows for lease liabilities as of December 31, 2024, is as follows:

---

| | | |
|:---|:---|:---|
| | Operating | Finance |
| <u>Year ending December 31,</u> | Leases | Leases |
| 2025 | $673 | $12 |
| 2026 | 692 | 12 |
| 2027 | 711 |  |
| 2028 | 354 |  |
| Total lease payments | 2430 | 24 |
| Less: Interest | (299) | (1) |
| Present value of lease liabilities | $2131 | $23 |

---

During the year ended December 31, 2024, the Company executed a sublease agreement that continues through the term of the master lease ending June 30, 2028. The agreement did not relieve the Company of its primary obligations under the master lease. During the year ended December 31, 2024, the Company recognized approximately $194 in sublease income. The sublease comprises substantially all the Company's future operating lease obligations through 2028.

**NOTE 13EMPLOYEE BENEFITS**

**<u>Retirement Plan</u>**

The Company has an employee 401(k) plan, which allows eligible employees to defer a portion of the income through plan contributions. The Company may make discretionary matching contributions. The Company made a matching contribution of approximately $312 and $332 for the years ended December 31, 2024 and 2023, respectively.

**NOTE 14INCOME TAXES**

The income tax expense consists of the following for the years ended December 31:

(25) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Current: |  |  |
| &nbsp;&nbsp;Federal | $923 | $1296 |
| &nbsp;&nbsp;State | 180 | 194 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 1103 | 1490 |
| Deferred: |  |  |
| &nbsp;&nbsp;Federal | (685) | 1510 |
| &nbsp;&nbsp;State | 164 | 189 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | (521) | 1699 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total income tax expense | $582 | $3189 |

---

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

A reconciliation of the statutory U.S. federal income tax rate to the Company's effective tax rate is as follows for the years ended December 31:

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Federal income tax benefit at statutory rate | 21.0% | 21.0% |
| State and local tax, net of federal benefit | 3.1% | 3.1% |
| Change in tax rates | (1.2)% | (4.6)% |
| Permanent differences | 0.1% | 1.1% |
| Tax credits | (1.4)% | —% |
| Federal and state deferred tax adjustments | (0.4)% | 780.6% |
| Return to provision adjustment | (10.6)% | 70.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Effective income tax rate | 10.6% | 871.3% |

---

Significant components of the Company's net deferred tax assets and liabilities are as follows as of December 31:

(26) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

---

| | | |
|:---|:---|:---|
| | 2024 | 2023 |
| Deferred tax assets: |  |  |
| &nbsp;&nbsp;Section 174 Costs | $1381 | $1355 |
| &nbsp;&nbsp;Business interest expense | 914 | 493 |
| &nbsp;&nbsp;Lease liabilities | 534 | 765 |
| &nbsp;&nbsp;Share-based compensation | 355 | 290 |
| &nbsp;&nbsp;Net operating loss carryforward | 215 | 252 |
| &nbsp;&nbsp;Other | 189 | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax assets | 3588 | 3348 |
| Deferred tax liabilities: |  |  |
| &nbsp;&nbsp;Goodwill | (2732) | (2566) |
| &nbsp;&nbsp;ROU asset | (398) | (599) |
| &nbsp;&nbsp;Other | (170) | (351) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax liabilities | (3300) | (3516) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax asset (liability), net | $288 | $(168) |

---

The Company had state and federal net operating loss carryovers of approximately $1,257 and $2,854 as of December 31, 2024 and 2023, respectively. State net operating loss carryover are subject to limitations by state. The federal net operating loss carryovers do not expire.

The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, and foreign jurisdictions, where applicable. The Company's tax years are still open from 2021 to present and, to the extent utilized in future years' tax returns, net operating loss carryforwards at December 31, 2024 will remain subject to examination until the respective tax year is closed.

**NOTE 15COMMITMENTS AND CONTINGENCIES**

The Company's contractual commitments consist of operating lease liabilities for office space that are included in the condensed consolidated balance sheets.

From time to time, the Company could be subject to legal proceedings arising in the normal course of its business activities. Depending on the nature and timing of any such dispute, an unfavorable resolution of a matter could materially affect the Company's future results of operations, cash flows or financial position. The Company records a liability for legal matters if and when such liability is probable and reasonably estimable. As of December 31, 2024 and 2023, the Company did not have any material recorded liabilities related to legal matters nor did the Company have any exposure to a reasonably possible material contingency.

**NOTE 16SUBSEQUENT EVENTS** 

On November 12, 2025, the Company sold 100% of its equity to Phreesia, Inc. for a base purchase price of $160,000, as defined in the agreement. The consideration transferred consisted entirely of cash. The Company's short-term and long-term debt were repaid in connection with the acquisition.

(27) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**DECEMBER 31, 2024 AND 2023**

(In thousands, except share and per-share data)

On September 23, 2025, the Company amended the PNC Agreement to extend its revolving credit agreement through December 31, 2025, at substantially the same terms. The PNC Agreement was terminated in connection with the acquisition.

(28)

## Exhibit 99.2

**Exhibit 99.2**

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024 AND**

**FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024**

------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**TABLE OF CONTENTS**

**AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024 AND**

**FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024**

**CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**CONDENSED CONSOLIDATED BALANCE SHEETS&nbsp;&nbsp;&nbsp;&nbsp;1**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS&nbsp;&nbsp;&nbsp;&nbsp;2**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY&nbsp;&nbsp;&nbsp;&nbsp;3**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS&nbsp;&nbsp;&nbsp;&nbsp;4**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&nbsp;&nbsp;&nbsp;[6](#ic5758d76f88d4ce4b410618c0692a791_31)**

------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(In thousands, except share and per share data)

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| **Assets** | (Unaudited) |  |
| **Current:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and restricted cash | $12692 | $11949 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | 66683 | 77675 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 1334 | 1202 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued interest and fees receivable, net of allowance for credit losses of $93 and $114 as of September 30, 2025 and December 31, 2024, respectively | 940 | 1052 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred purchase price receivable | 20120 | 16642 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term deferred contract acquisition costs | 29 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 559 | 1079 |
| **Total current assets** | 102357 | 109599 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term cardholder receivables, net | 79175 | 92445 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred purchase price receivable |  | 5012 |
| &nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets, net | 1291 | 1587 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 279 | 443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 172 | 683 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 71964 | 71964 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax asset | 288 | 288 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 411 | 1809 |
| **Total Assets** | $255937 | $283830 |
| **Liabilities and Stockholder's Equity** |  |  |
| **Current:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to health care providers | $71264 | $84328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 486 | 436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 1598 | 3545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of term loan, net | 34444 | 400 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of lease liabilities | 578 | 533 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenues | 25 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 173 |  |
| **Total current liabilities** | 108568 | 89242 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of due to health care providers | 83658 | 99560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of lease liabilities | 1159 | 1598 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of term loan, net |  | 33996 |
| **Total Liabilities** | 193385 | 224396 |
| **Commitments and contingencies (Note 12)** |  |  |
| **Stockholder's Equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value, 156,000 shares authorized, 30,963 and 30,934 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Convertible series A preferred stock, $0.0001 par value, 43,000 shares authorized, 39,547 shares issued and outstanding as of both September 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Convertible series B preferred stock, $0.0001 par value, 60,000 shares authorized, 51,323 shares issued and outstanding as of both September 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Convertible series C preferred stock, $0.0001 par value, 6,000 shares authorized, 5,641 shares issued and outstanding as of both September 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 68028 | 67720 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings (accumulated deficit) | (5476) | (8286) |
| **Total Stockholders' Equity** | 62552 | 59434 |
| **Total Liabilities and Stockholders' Equity** | $255937 | $283830 |

---

*See accompanying Notes to Condensed Consolidated Financial Statements.*

(1) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **For the nine months ended September 30,** | **For the nine months ended September 30,** |
| | **2025** | **2024** |
| **Revenues** | $34628 | $36380 |
| **Expenses:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenue (excluding depreciation and amortization) | 16104 | 15413 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 1244 | 1593 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 4536 | 4559 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 5037 | 5571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 180 | 240 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | 512 | 512 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total operating expenses** | 27613 | 27888 |
| **Operating income** | 7015 | 8492 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (3080) | (3777) |
| **Income before income tax expense** | 3935 | 4715 |
| **Income tax expense** | (1125) | (527) |
| **Net income** | $2810 | $4188 |

---

*See accompanying Notes to Condensed Consolidated Financial Statements.*

(2) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY**

(In thousands, except share amounts)

(Unaudited)

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **Convertible** | **Convertible** | **Convertible** | **Convertible** | **Convertible** | **Convertible** | | | |
| | | | **Series A** | **Series A** | **Series B** | **Series B** | **Series C** | **Series C** | | | |
| | **Common Stock** | **Common Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** | | | |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** |<br>**Additional**<br>**Paid-In**<br>**Capital** |<br>**Accumulated**<br>**Deficit** |<br>**Stockholders'**<br>**Equity** |
| **Balance December 31, 2023** | 30905 | $— | 39547 | $— | 51323 | $— | 5641 | $— | $67257 | $(13195) | $54062 |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  |  |  |  |  | 4188 | 4188 |
| &nbsp;&nbsp;&nbsp;Stock incentive compensation |  |  |  |  |  |  |  |  | 159 |  | 159 |
| &nbsp;&nbsp;&nbsp;Exercised stock options | 29 |  |  |  |  |  |  |  | 7 |  | 7 |
| &nbsp;&nbsp;&nbsp;Paid-in capital |  |  |  |  |  |  |  |  | (7) |  | (7) |
| **Balance September 30, 2024** | 30934 | $— | 39547 | $— | 51323 | $— | 5641 | $— | $67416 | $(9007) | $58409 |
| **Balance December 31, 2024** | 30934 | $— | 39547 | $— | 51323 | $— | 5641 | $— | $67720 | $(8286) | $59434 |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  |  |  |  |  | 2810 | 2810 |
| &nbsp;&nbsp;&nbsp;Stock incentive compensation |  |  |  |  |  |  |  |  | 247 |  | 247 |
| &nbsp;&nbsp;&nbsp;Exercised stock options | 29 |  |  |  |  |  |  |  | 64 |  | 64 |
| &nbsp;&nbsp;&nbsp;Paid-in capital |  |  |  |  |  |  |  |  | (3) |  | (3) |
| **Balance September 30, 2025** | 30963 | $— | 39547 | $— | 51323 | $— | 5641 | $— | $68028 | $(5476) | $62552 |

---

*See accompanying Notes to Condensed Consolidated Financial Statements.*

(3) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **For the nine months ended<br> September 30,** | **For the nine months ended<br> September 30,** |
| | **2025** | **2024** |
| Net cash provided by operating activities |  |  |
| Net income | $2810 | $4188 |
| Adjustments to reconcile net income to net cash provided by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 692 | 752 |
| &nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 320 | 300 |
| &nbsp;&nbsp;&nbsp;Non-cash operating lease expense | 296 | 300 |
| &nbsp;&nbsp;&nbsp;Stock incentive compensation | 247 | 159 |
| &nbsp;&nbsp;&nbsp;Accrued interest on stock purchase receivable | (3) | (9) |
| &nbsp;&nbsp;&nbsp;Deferred taxes |  | (716) |
| &nbsp;&nbsp;&nbsp;Other cash provided by (used for) securitization program | 850 | (157) |
| Changes in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | (132) | 299 |
| &nbsp;&nbsp;&nbsp;Accrued interest receivable | 112 | 237 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | 1890 | 573 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (1901) | 202 |
| &nbsp;&nbsp;&nbsp;Lease liabilities | (394) | (400) |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 197 |  |
| Net cash provided by operating activities | 4984 | 5728 |
| Cash flows from investing activities |  |  |
| &nbsp;&nbsp;&nbsp;Collections of DPP receivable | 11770 | 405 |
| &nbsp;&nbsp;&nbsp;Collections of unfunded cardholder receivables | 80912 | 76501 |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (12) | (47) |
| Net cash provided by investing activities | 92670 | 76859 |
| Cash flows from financing activities |  |  |
| &nbsp;&nbsp;&nbsp;Repurchase of stock options |  | (99) |
| &nbsp;&nbsp;&nbsp;Capitalization of debt issuance costs |  | (16) |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock | 65 | 7 |
| &nbsp;&nbsp;&nbsp;Payments of due to health care providers for unfunded receivables | (96704) | (81476) |
| &nbsp;&nbsp;&nbsp;Payments on term loan | (272) | (252) |
| Net cash used in financing activities | (96911) | (81836) |
| Net increase in cash and restricted cash | 743 | 751 |
| Cash and restricted cash - beginning of year | 11949 | 5668 |
| Cash and restricted cash - end of year | $12692 | $6419 |
| **SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $3692 | $3692 |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes | $— |  |
| **RECONCILIATION OF CASH AND RESTRICTED CASH SHOWN IN STATEMENTS OF CASH FLOWS** | **RECONCILIATION OF CASH AND RESTRICTED CASH SHOWN IN STATEMENTS OF CASH FLOWS** |  |
| &nbsp;&nbsp;&nbsp;Cash and restricted cash per balance sheets | $12692 | $4946 |
| &nbsp;&nbsp;&nbsp;Restricted cash included in long-term other assets |  | 1473 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cash and restricted cash shown in statements of cash flows | $12692 | $6419 |

---

*See accompanying Notes to Condensed Consolidated Financial Statements.*

(4) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| **NON-CASH INVESTING AND FINANCING ACTIVITIES** | | |
| Non-cash activities related to credit card receivables and deferred purchase price | $57502 | $87787 |

---

*See accompanying Notes to Condensed Consolidated Financial Statements.*

(5) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

**NOTE 1ORGANIZATION AND NATURE OF OPERATIONS**

AccessOne Parent Holdings, Inc. (AccessOne Parent Holdings), a Delaware Corporation formed in November 2021 headquartered in Fort Mill, South Carolina, is the parent company of its wholly owned subsidiary, AccessOne Holdings, Inc (Holdings). Holdings is a holding company of its wholly owned operating entities, AccessOne MedCard, Inc. (AccessOne MedCard) and CueSquared, Inc. (CueSquared). AccessOne Funding, LLC (AccessOne Funding) is a wholly owned subsidiary of AccessOne MedCard (collectively the Company).

AccessOne MedCard is a leading technology-enabled financial services corporation that helps patients manage their out-of-pocket health care costs while offering health care providers a comprehensive, compliant, and patient-friendly solution for improving access to care and collection of self-pay patient receivables on a recourse basis. CueSquared offers a cloud-based direct mobile payment platform and analytics dashboard for health care providers.

The Company principally derives its revenues from finance charges on cardholder receivables, servicing fees earned for administering self-pay patient accounts on behalf of health care providers, and fees generated through CueSquared's direct mobile payment (DMP) platform. Additional revenues include late fees and other service charges assessed on patient accounts. These revenue streams are generated through the Company's technology-enabled payment solutions, which facilitate patient financing and enhance provider collections.

**NOTE 2SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

The Company's significant accounting policies are unchanged from the audited consolidated financial statements for the years ended December 31, 2024 and 2023.

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company's interim financial position as of September 30, 2025 and December 31, 2024 and the results of its operations, changes in its stockholders' equity and its cash flows for the nine months ended September 30, 2025 and 2024. The results for the interim periods are not necessarily indicative of results to be expected for the full year, any other interim periods, or any future year or period. The Company's management believes that the disclosures herein are adequate to make the information presented not misleading when read in conjunction with the audited consolidated financial statements and accompanying notes for the years ended December 31, 2024 and 2023.

**<u>Concentration of Credit Risk</u>**

Substantially all cash is deposited in one financial institution. At times, amounts on deposit may be in excess of the Federal Deposit Insurance Corporation (FDIC) insurance limit.

(6) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

For the nine months ended September 30, 2025 and 2024, the Company derived approximately 64% and 60%, respectively, of its revenue from three health care providers and the patients of those providers.

As of September 30, 2025 and December 31, 2024, approximately 80% and 83%, respectively, of the Company's outstanding cardholder receivables were from patients of two health care providers.

The loss of one of these health care providers as a customer could have a significant impact on the Company's financial position, results of operations, and cash flows.

**<u>Cash and Restricted Cash</u>**

For purposes of the condensed consolidated statements of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. Substantially all cash is deposited in one financial institution.

As of September 30, 2025 and December 31, 2024, the Company was required to maintain $5,000 of liquidity, which includes unrestricted cash and availability under its credit and securitization agreements. The Company was in compliance with these requirements as of September 30, 2025 and December 31, 2024.

The Company believes that cash from its operations during the next 12 months will be sufficient to continue to operate as a going concern for the next 12 months.

<u>Restricted Cash</u>

As a part of the *Cardholder Receivables Securitization Program* disclosed within Note 6, the Company is required to maintain a cash reserve account equal to 1% of the outstanding receivable in the securitization. The restricted cash balance is legally segregated and not available for general corporate purposes. Restricted cash totaled $1,691 as of September 30, 2025 and was classified as a current asset and included within cash and restricted cash on the consolidated balance sheets. Restricted cash totaled $1,691 as of December 31, 2024 and was classified as a long-term asset and included within other assets on the consolidated balance sheets.

**<u>Subsequent Events</u>**

In preparing these condensed consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through January 28, 2026, the date the condensed consolidated financial statements were available to be issued. See Note 13.

(7) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

**NOTE 3CARDHOLDER RECEIVABLES, NET**

The Company has a portfolio of cardholder receivables that consist of the following as of September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| Short-term cardholder receivables | Short-term cardholder receivables | Short-term cardholder receivables |
|  | 2025 | 2024 |
| Short-term cardholder receivables | $71631 | $83469 |
| Deferred origination fees | (4948) | (5794) |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | $66683 | $77675 |
| Long-term cardholder receivables | Long-term cardholder receivables | Long-term cardholder receivables |
|  | 2025 | 2024 |
| Long-term cardholder receivables | $85051 | $99340 |
| Deferred origination fees | (5876) | (6895) |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | $79175 | $92445 |
| Total cardholder receivables | Total cardholder receivables | Total cardholder receivables |
|  | 2025 | 2024 |
| Cardholder receivables | $156682 | $182809 |
| Deferred origination fees | (10824) | (12689) |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables, net | $145858 | $170120 |

---

The Company elected to exclude accrued interest receivable from the amortized cost basis of cardholder receivables.

All cardholder receivables are subject to a recourse agreement with the respective selling health care provider and no allowance for credit loss is required.

After 90 days of non-payment, cardholder receivables are returned to the provider and the related due to provider liability is extinguished. Accordingly, all outstanding cardholder receivables are aged less than 90 days..

**NOTE 4ACCOUNTS RECEIVABLE**

The following summarizes the components of accounts receivable as of September 30, 2025 and December 31, 2024:

(8) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

---

| | | |
|:---|:---|:---|
| | 2025 | 2024 |
| Accounts receivable | $1334 | $1202 |
| Allowance for credit losses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable, net | $1334 | $1202 |

---

At September 30, 2025 and December 31, 2024, management determined an allowance for credit losses was not necessary.

**NOTE 5CARDHOLDER RECEIVABLE SECURITIZATION PROGRAM**

The Company has a securitization program to sell cardholder receivables to PNC Bank (PNC). Once sold to PNC, the Company has no retained interests in the cardholder receivables and the cardholder receivables sold are derecognized from the Company's condensed consolidated balance sheets.

Under the program, AccessOne MedCard sells cardholder receivables to AccessOne Funding, a special-purpose entity (SPE), for an amount equal to their face value. The SPE is a VIE for which AccessOne Holdings is the primary beneficiary. The SPE's sole business consists of the purchase of receivables from AccessOne MedCard and the subsequent sale of cardholder receivables to PNC. Although the SPE is included in the Company's condensed consolidated financial statements, it is a separate legal entity with separate creditors. AccessOne Funding then sells the cardholder receivables to PNC for an initial cash purchase price (equal to the nominal amount of such receivables) and the right to receive a deferred purchase price (DPP).

The DPP reflects the portion of the purchase price for the cardholder receivables which is not paid in cash. It is a beneficial interest in the sold cardholder receivables and is recognized as part of the sale transaction. The DPP functions as a credit enhancement and is settled from collections of securitized cardholder receivables by the Company. Repayment of the DPP is conditional on the performance of the securitized cardholder receivables.

The cardholder securitization program has a maturity date, after amendments, of February 3, 2026. This program can be renewed with consent from the parties.

The following table summarizes the sold cardholder receivables outstanding balance, net of DPP asset, under the outstanding securitization program as of and for the periods ended September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| | 2025 | 2024 |
| Sold receivables at the beginning of the year | $187690 | $167354 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sale of cardholder receivables | 111427 | 183763 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash collections (remitted to PNC) | (124563) | (163428) |
| Sold receivables at the end of the year | $174554 | $187690 |

---

The Company incurs securitization-related costs including deferred costs. Securitization-related costs of $7,349 and $7,768 were included in cost of revenue (excluding depreciation and amortization) in the condensed consolidated statements of operations for the nine months ended September 30, 2025 and 2024, respectively.

(9) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

Eligible costs are capitalized and amortized over the term of program. The unamortized balance of the capitalized securitization costs at September 30, 2025 and December 31, 2024 was approximately $206 and $476, and is reported in prepaid expenses and other assets on the condensed consolidated balance sheets. The Company included $320 and $296 of expense within cost of revenue (excluding depreciation and amortization) in the condensed consolidated statements of operations for the nine months ended September 30, 2025 and 2024, respectively.

**NOTE 6PROPERTY AND EQUIPMENT, NET**

Property and equipment consisted of the following as of September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| | 2025 | 2024 |
| Computer equipment | $923 | $943 |
| Software | 1801 | 1787 |
| Leasehold improvements | 1062 | 1062 |
| Furniture and fixtures | 345 | 345 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 4131 | 4137 |
| Less: Accumulated depreciation | (3852) | (3694) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | $279 | $443 |

---

Depreciation expense for the nine months ended September 30, 2025 and 2024 was approximately $180 and $240, respectively.

(10) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

**NOTE 7INTANGIBLE ASSETS AND GOODWILL**

Following is a summary of intangible assets as of September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| | 2025 | 2024 |
| Developed technology | $500 | $500 |
| Acquired customer relationships | 1400 | 1400 |
| Tradename | 150 | 150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 2050 | 2050 |
| Less: Accumulated amortization of developed technology and acquired customer relationships | (1878) | (1367) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total intangible assets, net | $172 | $683 |

---

Amortization expense for both the nine months ended September 30, 2025 and 2024 was approximately $512.

The Company assesses goodwill for impairment on an annual basis as of December 31, or when indicators of impairment are identified. The Company did not record any impairments of goodwill during the nine months ended September 30, 2025 and 2024.

**NOTE 8REVOLVING LOAN, NET**

The Company has a revolving credit agreement with PNC (PNC Agreement) providing for maximum available borrowing capacity on revolving loans of $2,500, including a letter of credit subfacility as of September 30, 2025 and December 31, 2024. Amounts borrowed under the PNC Agreement may be repaid and re-borrowed at any time prior to the maturity date of December 31, 2025, at which time all principal and interest are due. The revolving loans are collateralized by all assets of the Company.

The revolving commitment provides for both Secured Overnight Financing Rate (SOFR) and Base Rate loans, and the loan type dictates the interest rate charged on the balance outstanding. Loans may be converted from a SOFR loan to a base rate loan at any time.

Interest on the revolving line of credit is charged monthly, on a variable rate basis, at the rate per annum equal to the daily simple SOFR plus a margin of 4.00% for SOFR loans, or the greater of the Overnight Bank Funding Rate plus 0.5%, or *WSJ* Prime Rate, or the daily simple SOFR plus 1.00%, plus a margin of 3.00% for Base Rate loans. All loans are subject to an interest rate floor of 0.50%.

The daily simple SOFR is published by the Federal Reserve Bank of New York (4.96% at September 30, 2025) and is subject to adjustments as defined in the agreement, depending on the date the SOFR is computed and the SOFR reserve percentage.

The PNC Agreement includes an unused line fee (0.25% at September 30, 2025) of the difference between the commitment and the average daily balance of the revolving loans.

There was no balance outstanding on the PNC Agreement as of September 30, 2025 and December 31, 2024.

(11) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

The PNC Agreement subjects the Company to certain financial and nonfinancial covenants. As of September 30, 2025, the Company was in compliance with the respective financial and nonfinancial covenants.

On September 23, 2025, the Company amended the PNC Agreement to extend its revolving credit agreement through December 31, 2025, at substantially the same terms. The PNC Agreement was terminated in connection with the acquisition.

**NOTE 9TERM LOAN, NET**

The Company entered into a credit agreement with CCP Agency, LLC (the Comvest loan) for $40,000. Following the initial funds, the Company may request additional term loans (incremental term loans) not to exceed $50,000 in the aggregate.

The revolving commitment provides for both SOFR and Base Rate loans, and the loan type dictates the interest rate charged on the balance outstanding. Loans may be converted from a SOFR loan to a base rate loan at any time.

Interest on the borrowed funds is charged monthly, on a variable basis, at the rate per annum equal to the SOFR plus the applicable margin as defined in the agreement, for SOFR loans, or at the rate per annum equal to the Base Rate plus the applicable margin as defined in the agreement, for Base Rate loans.

The SOFR is published by the Federal Reserve Bank of New York (4.96% and 4.49% at September 30, 2025 and December 31, 2024, respectively) and is subject to adjustments as defined in the agreement.

At September 30, 2025 and December 31, 2024, the loan was a SOFR loan and was assessed interest at 10.46% and 10.67% per annum, respectively.

The Company incurred debt issuance costs which are amortized over the term of the loan. Amortization expense totaled approximately $321 and $319 and was reported as interest expense on the condensed consolidated statements of operations for the nine months ended September 30, 2025 and 2024, respectively.

The loan includes financial covenants including, but not limited to, requiring the Company to maintain minimum liquidity, a minimum Fixed Charge Coverage ratio, a maximum Senior Leverage Ratio, and a maximum Percentage of Recourse Put-Backs. The Company was in compliance with all covenants related to the Credit Agreement as of September 30, 2025.

The short-term and long-term debt were repaid in connection with the acquisition by Phreesia, Inc. Refer to Note 13 - Subsequent Events for additional information.

The balance of term loan, net consisted of the following as of September 30 2025 and December 31, 2024:

(12) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

---

| | | |
|:---|:---|:---|
| | 2025 | 2024 |
| Current portion of term loan | $35121 | $408 |
| Unamortized debt issuance costs | (677) | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term loan, net | $34444 | $400 |
| Long-term portion of term loan | $— | $34665 |
| Unamortized debt issuance costs |  | (669) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of term loan, net | $— | $33996 |

---

Beginning September 30, 2021, and on the last day of each fiscal quarter to occur thereafter, the Company must repay $100 of the initial term loan as well as 0.25% of the original principal amount of each such incremental term loan advance. The loan matures on August 20, 2026, at which point the remaining outstanding principal amount of the initial term loan and any incremental term loan advance is due.

Maturities of the term loan, net are as follows at September 30, 2025:

---

| | |
|:---|:---|
| <u>Year Ending December 31,</u> |  |
| 2025 | $400 |
| 2026 | 34721 |
| Total | $35121 |

---

As of September 31, 2025 and December 31, 2024, the fair value of debt approximated its unpaid principal amount.

**NOTE 10STOCKHOLDERS' EQUITY**

The rights, preferences, and privileges of the Company's common stock, preferred stock, and stock incentive plan remain unchanged from those disclosed in the audited consolidated financial statements for the years ended December 31, 2024 and 2023.

**NOTE 11INCOME TAXES**

The Company recorded income tax expense of $1,125 and $527 during the nine months ended September 30, 2025 and 2024, respectively. The Company's tax expense was 29% and 11% of income before income tax expense for the nine months ended September 30, 2025 and 2024, respectively.

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

The Company's provision for income taxes differs from applying the statutory U.S. federal income tax rate to income before income taxes. The primary differences result from state income taxes and permanent differences that are amortized or expensed for financial statement purposes but not for U.S. federal income tax purposes.

(13) ------

**ACCESSONE PARENT HOLDINGS, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except share and per-share data)

**NOTE 12COMMITMENTS AND CONTINGENCIES**

The Company's contractual commitments consist of operating lease liabilities for office space that are included in the condensed consolidated balance sheets.

From time to time, the Company could be subject to legal proceedings arising in the normal course of its business activities. Depending on the nature and timing of any such dispute, an unfavorable resolution of a matter could materially affect the Company's future results of operations, cash flows or financial position. The Company records a liability for legal matters if and when such liability is probable and reasonably estimable. As of September 30, 2025 and December 31, 2024, the Company did not have any material recorded liabilities related to legal matters nor did the Company have any exposure to a reasonably possible material contingency.

**NOTE 13SUBSEQUENT EVENTS** 

On November 12, 2025, the Company sold 100% of its equity to Phreesia, Inc. for a base purchase price of $160,000, as defined in the agreement. The consideration transferred consisted entirely of cash. The Company's short-term and long-term debt were repaid in connection with the acquisition.

On December 3, 2025, the Company extended its securitization facility with PNC through May 4, 2026.

(14)

## Exhibit 99.3

**Exhibit 99.3**

**UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION**

On November 12, 2025, Phreesia, Inc. ("Phreesia" or the "Company") completed its acquisition (the "Acquisition") of AccessOne Parent Holdings, Inc. and its subsidiaries ("AccessOne"). In connection with the Acquisition, the Company entered into a new secured term loan (the "Bridge Loan"), the net proceeds of which were used to fund a portion of the purchase price of the Acquisition, with the remainder funded by cash on hand. The unaudited pro forma condensed combined financial information presented below is derived from the historical consolidated financial statements of Phreesia and the historical consolidated financial statements of AccessOne, adjusted to give effect to the Acquisition and the Bridge Loan.

The unaudited pro forma condensed combined financial information was prepared in accordance with Article 11 of Regulation S-X using the assumptions set forth in the notes to the unaudited pro forma condensed combined financial information. The unaudited pro forma condensed combined financial information has been adjusted to include adjustments, which reflect the application of the accounting required by generally accepted accounting principles in the United States ("GAAP"), and rules of the Securities and Exchange Commission (the "SEC"), and linking the effects of the Acquisition and the Bridge Loan to the historical combined financial statements (the "Transaction Accounting Adjustments" and the "Other Transaction Accounting Adjustments," respectively).

The unaudited pro forma condensed combined balance sheet as of October 31, 2025 gives pro forma effect to the Acquisition and the Bridge Loan as if they had been completed and entered into, respectively, on October 31, 2025. The unaudited pro forma condensed combined statements of operations for the nine months ended October 31, 2025 and for the year ended January 31, 2025 give pro forma effect to the Acquisition and Bridge Loan as if they had been completed and entered into, respectively, on February 1, 2024. The Company's fiscal year ends on January 31, while AccessOne's fiscal year ends on December 31. While a one-month difference in fiscal year ends exists, no adjustment for this difference was made in the unaudited pro forma condensed combined balance sheet or the unaudited pro forma condensed combined statements of operations. Accordingly, the unaudited pro forma condensed combined balance sheet includes AccessOne's financial information as of September 30, 2025 and the unaudited pro forma condensed combined statements of operations include the nine months ended September 30, 2025 and the year ended December 31, 2024.

The unaudited pro forma condensed combined financial information is for illustrative and informational purposes only. It is not necessarily indicative of the operating results that would have occurred if the Acquisition had been completed as of the dates indicated in each pro forma presentation, nor is it indicative of the future combined results of operations or financial position of the Company. Further, Transaction Accounting Adjustments and Other Transaction Accounting Adjustments represent management's best estimates based on information available as of the date of this filing. They are subject to change as additional information becomes available.

The pro forma adjustments reflecting the completion of the Acquisition in this unaudited pro forma condensed combined financial information have been prepared using the acquisition method of accounting under Accounting Standards Codification Topic 805, *Business Combinations*. The unaudited pro forma condensed combined financial information is based on the assumptions and adjustments that are described in the accompanying notes. The application of the acquisition method of accounting depends on specific valuations and other studies that have yet to be completed. Accordingly, the acquisition adjustments included in the unaudited condensed combined pro forma financial information are preliminary, subject to further revision as additional information becomes available and additional analyses are performed, and have been made solely for the purpose of providing unaudited pro forma condensed combined financial information. There can be no assurances that the final valuations will not result in material changes to the preliminary estimated purchase price allocation. The unaudited pro forma condensed combined financial information does not give effect to the potential impact of current financial conditions, any anticipated synergies, operating efficiencies or cost savings that may result from the Acquisition or any integration costs. The actual results reported in periods following the Acquisition may differ significantly from those reflected in this unaudited pro forma condensed combined financial information presented herein for several reasons, including, but not limited to, differences between the assumptions used to prepare this unaudited pro forma condensed combined financial information and actual results.

------

The assumptions and estimates underlying the unaudited adjustments to the unaudited pro forma condensed combined financial statements are described in the accompanying notes, which should be read together with the unaudited pro forma condensed combined financial statements.

The following unaudited pro forma condensed combined financial information and accompanying notes are based on and should be read in conjunction with (i) Phreesia's Annual Report on Form 10-K for the year ended January 31, 2025, (ii) Phreesia's Quarterly Report on Form 10-Q for the nine months ended October 31, 2025, (iii) the historical audited consolidated financial statements of AccessOne Parent Holdings, Inc. and Subsidiaries as of and for the years ended December 31, 2024 and 2023, which are included in Exhibit 99.1 to this Current Report on Form 8-K, and (iv) the historical unaudited condensed consolidated financial statements of AccessOne Parent Holdings, Inc. and Subsidiaries as of September 30, 2025 and December 31, 2024 and for the nine months ended September 30, 2025 and 2024, which are included in Exhibit 99.2 to this Current Report on Form 8-K.

------

**Unaudited Pro forma Condensed Combined Balance Sheet**

**As of October 31, 2025**

(in thousands)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Phreesia<br>(Historical)** | **AccessOne<br>(Historical)** | **Transaction Accounting Adjustments** | | **Other Transaction Accounting Adjustments** | | **Pro forma<br>Combined** |
| **Assets** | | | | | | | |
| **Current:** | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents, and restricted cash | $106371 | $12692 | $(171936) | a | $106878 | i | $54005 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlement assets | 25391 |  |  |  |  |  | 25391 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 88257 | 1334 | (626) | b |  |  | 88965 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cardholder receivables |  | 66683 | (24146) | b |  |  | 42537 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred purchase price receivable |  | 20120 | (1240) | b |  |  | 18880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued interest and fees receivable |  | 940 | (546) | b |  |  | 394 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred contract acquisition costs | 427 | 29 | (29) | b |  |  | 427 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 20460 | 559 | (183) | b |  |  | 20836 |
| **Total current assets** | 240906 | 102357 | (198706) |  | 106878 |  | 251435 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 21111 | 279 | (23) | b |  |  | 21367 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capitalized internal-use software, net | 54093 |  |  |  |  |  | 54093 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 820 | 1291 | 568 | b |  |  | 2679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred contract acquisition costs | 444 |  |  |  |  |  | 444 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 25532 | 172 | 66428 | c |  |  | 92132 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 75845 | 71964 | 5703 | c |  |  | 153512 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred tax asset | 1640 | 288 | (288) | b |  |  | 1640 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term cardholder receivables |  | 79175 | (27186) | b |  |  | 51989 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred purchase price receivable |  |  | 5639 | b |  |  | 5639 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 3081 | 411 | (204) | b |  |  | 3288 |
| **Total Assets** | $423472 | $255937 | $(148069) |  | $106878 |  | $638218 |
| **Liabilities and Stockholders' Equity** |  |  |  |  |  |  |  |
| **Current:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlement obligations | $25391 | $— | $— |  | $— |  | $25391 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of finance lease liabilities and other debt | 6199 | 34444 | (34444) | d | 106878 | ii | 113077 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 746 | 578 | 107 | b |  |  | 1431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 6218 | 486 | 166 | b |  |  | 6870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 30517 | 1598 | 1617 | e |  |  | 33732 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of due to health care providers |  | 71264 | (29519) | b |  |  | 41745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 29712 | 25 | (5) | b |  |  | 29732 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities |  | 173 | (6) | b |  |  | 167 |
| **Total current liabilities** | 98783 | 108568 | (62084) |  | 106878 |  | 252145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term finance lease liabilities and other debt | 3353 |  |  |  |  |  | 3353 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, non-current | 132 | 1159 | 15 | b |  |  | 1306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred revenue | 151 |  |  |  |  |  | 151 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred tax liabilities | 683 |  | 2425 | f |  |  | 3108 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term due to health care providers |  | 83658 | (32637) | b |  |  | 51021 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other long-term liabilities | 41 |  |  |  |  |  | 41 |
| **Total Liabilities** | 103143 | 193385 | (92281) |  | 106878 |  | 311125 |
| **Commitments and contingencies** |  |  |  |  |  |  |  |
| **Stockholders' Equity:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock | 616 |  |  |  |  |  | 616 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1166078 | 68028 | (68028) | g |  |  | 1166078 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (800485) | (5476) | 12240 | g |  |  | (793721) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss) | (360) |  |  |  |  |  | (360) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost | (45520) |  |  |  |  |  | (45520) |
| **Total Stockholders' Equity** | 320329 | 62552 | (55788) |  |  |  | 327093 |
| **Total Liabilities and Stockholders' Equity** | $423472 | $255937 | $(148069) |  | $106878 |  | $638218 |

---

The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.

------

**Unaudited Pro forma Condensed Combined Statement of Operations**

**Nine Months Ended October 31, 2025**

(in thousands, except share and per share data)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Phreesia (Historical)** | **AccessOne (Historical)** | **Transaction Accounting Adjustments** | | **Other Transaction Accounting Adjustments** | | **Pro forma<br>Combined** |
| **Revenue:** | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subscription and related services | $163537 | $— | $— |  | $— |  | $163537 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment solutions | 85739 | 34628 |  |  |  |  | 120367 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Network solutions | 104248 |  |  |  |  |  | 104248 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total revenues** | 353524 | 34628 |  |  |  |  | 388152 |
| **Expenses:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenue (excluding depreciation and amortization) | 52373 |  |  |  |  |  | 52373 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment solutions cost of revenue (excluding depreciation and amortization) | 61360 | 16104 |  |  |  |  | 77464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 75587 | 1244 |  |  |  |  | 76831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 90556 | 4536 |  |  |  |  | 95092 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 52938 | 5037 |  |  |  |  | 57975 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 9464 | 180 |  |  |  |  | 9644 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | 12301 | 512 | 6288 | h |  |  | 19101 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total expenses** | 354579 | 27613 | 6288 |  |  |  | 388480 |
| **Operating (loss) income** | (1055) | 7015 | (6288) |  |  |  | (328) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | 1680 |  |  |  |  |  | 1680 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income (expense), net | 758 | (3080) | 3080 | i | (8942) | iii | (8184) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total other income (expense), net** | 2438 | (3080) | 3080 |  | (8942) |  | (6504) |
| **Income (loss) before income tax (expense) benefit** | 1383 | 3935 | (3208) |  | (8942) |  | (6832) |
| **Income tax (expense) benefit** | (372) | (1125) | 786 | j |  | iv | (711) |
| **Net income (loss)** | $1011 | $2810 | $(2422) |  | $(8942) |  | $(7543) |
| **Net income (loss) per share attributable to common stockholders:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Basic** | $0.02 |  |  |  |  |  | $(0.13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Diluted** | $0.02 |  |  |  |  |  | $(0.13) |
| **Weighted-average common shares outstanding:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Basic** | 59513478 |  |  |  |  |  | 59513478 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Diluted** | 61491761 |  | (1978283) | k |  |  | 59513478 |

---

The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.

------

**Unaudited Pro forma Condensed Combined Statement of Operations**

**Year Ended January 31, 2025**

(in thousands, except share and per share data)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Phreesia <br>(Historical)** | **AccessOne<br>(Historical)** | **Transaction Accounting Adjustments** | | **Other Transaction Accounting Adjustments** | | **Pro forma Combined** |
| **Revenue:** | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subscription and related services | $196510 | $— | $— |  | $— |  | $196510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment solutions | 101740 | 49217 |  |  |  |  | 150957 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Network solutions | 121563 |  |  |  |  |  | 121563 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total revenues** | 419813 | 49217 |  |  |  |  | 469030 |
| **Expenses:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenue (excluding depreciation and amortization) | 66227 |  |  |  |  |  | 66227 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment solutions cost of revenue (excluding depreciation and amortization) | 68707 | 21820 |  |  |  |  | 90527 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 121129 | 1697 |  |  |  |  | 122826 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 117364 | 6192 |  |  |  |  | 123556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 76597 | 8108 | 6892 | l |  |  | 91597 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 14183 | 312 |  |  |  |  | 14495 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | 13703 | 684 | 8383 | h |  |  | 22770 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total expenses** | 477910 | 38813 | 15275 |  |  |  | 531998 |
| **Operating (loss) income** | (58097) | 10404 | (15275) |  |  |  | (62968) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | 1956 |  |  |  |  |  | 1956 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income (expense), net | 330 | (4913) | 4913 | i | (11922) | iii | (11592) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total other income (expense), net** | 2286 | (4913) | 4913 |  | (11922) |  | (9636) |
| **(Loss) income before income tax (expense) benefit** | (55811) | 5491 | (10362) |  | (11922) |  | (72604) |
| **Income tax (expense) benefit** | (2716) | (582) | 14532 | j |  | iv | 11234 |
| **Net (loss) income** | $(58527) | $4909 | $4170 |  | $(11922) |  | $(61370) |
| **Net loss per share attributable to common stockholders:** |  |  |  |  |  |  |  |
| Basic | $(1.02) |  |  |  |  |  | $(1.07) |
| Diluted | $(1.02) |  |  |  |  |  | $(1.07) |
| Weighted-average common shares outstanding: |  |  |  |  |  |  |  |
| Basic | 57589687 |  |  |  |  |  | 57589687 |
| Diluted | 57589687 |  |  |  |  |  | 57589687 |

---

The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.

------

**Notes To Unaudited Pro Forma Condensed Combined Financial Information**

**Note 1. Basis of Presentation and Description of the Acquisition**

The unaudited pro forma condensed combined financial information was prepared in accordance with Article 11 of Regulation S-X and presents the pro forma financial condition and results of operations based upon the historical financial information after giving effect to the Acquisition and related adjustments set forth in the notes to the unaudited pro forma condensed combined financial information.

Phreesia's fiscal year ends on January 31, while AccessOne's fiscal year ends on December 31. While a one-month difference in fiscal year ends exists, no adjustment for this difference was made in the unaudited pro forma condensed combined balance sheet or the unaudited pro forma condensed combined statements of operations. Accordingly, the unaudited pro forma condensed combined balance sheet includes AccessOne's financial information as of September 30, 2025 and the unaudited pro forma condensed combined statements of operations include the nine months ended September 30, 2025 and the year ended December 31, 2024.

The unaudited pro forma condensed combined balance sheet as of October 31, 2025 gives pro forma effect to the Acquisition and the Bridge Loan as if they had been completed and entered into, respectively, on October 31, 2025. The unaudited pro forma condensed combined statements of operations for the nine months ended October 31, 2025 and for the year ended January 31, 2025 give pro forma effect to the Acquisition and the Bridge Loan as if they had been completed and entered into, respectively, on February 1, 2024. The historical financial statements of Phreesia and AccessOne have been adjusted to give pro forma effect to events that are directly attributable to the Acquisition and the Bridge Loan, and where management believes there is a reasonable and supportable basis for the adjustment. Transaction Accounting Adjustments and Other Transaction Accounting Adjustments do not reflect any anticipated synergies, cost savings, or integration costs and are factually supportable and directly related to the Acquisition.

***Description of the Acquisition and Bridge Loan***

On August 29, 2025, the Company entered into a definitive agreement (the "Merger Agreement") to acquire 100% of the outstanding equity of AccessOne. The Acquisition was completed on November 12, 2025 (the "Closing Date") for total consideration of $163.7 million. The purchase price for the Acquisition does not include any contingent consideration, earn-outs, or seller notes.

The Acquisition was funded with a combination of cash and the net proceeds from the Bridge Loan, a secured term loan, entered into on the Closing Date with Goldman Sachs Bank USA. The Bridge Loan has an outstanding principal amount of $110.0 million and bears interest at a per annum rate equal to the three-month Secured Overnight Financing Rate ("SOFR") plus a margin of 4.00% per annum. The Bridge Loan matures on November 11, 2026. The interest rate applicable to the Bridge Loan will increase by 0.5% every three months following the Closing Date. The Company incurred approximately $3.1 million in debt discount consisting of $1.2 of debt issuance costs and $1.9 million of original issue discount related to the Bridge Loan. Net proceeds of the Bridge Loan were $106.9 million, which represents the principal of the Bridge Loan less the debt discount.

The Acquisition was accounted for under the acquisition method in accordance with Accounting Standards Codification Topic 805, *Business Combinations* ("ASC 805"). In accordance with ASC 805, the assets acquired and liabilities assumed have been measured at fair value based on various estimates and methodologies, including the income and market approaches. The excess of the fair value of purchase consideration over the values of the identifiable assets and liabilities is recorded as goodwill. Under the acquisition method, acquisition-related transaction costs (e.g., advisory, legal, valuation and other professional fees) are not included as consideration transferred but are accounted for as expenses in the periods in which the costs are incurred.

When determining the fair value of assets acquired and liabilities assumed, the Company makes significant estimates and assumptions, especially with respect to fair value of identifiable intangible assets. These estimates are based on key assumptions related to the Acquisition, including reviews of publicly disclosed information for other acquisitions in the industry, historical experience of the Company, data that was available through the public domain and unobservable inputs, such as historical financial information of the acquired business.

The Company has not yet finalized a valuation analysis of the fair value of AccessOne's assets to be acquired and liabilities to be assumed, including identifiable intangible assets. Using the estimated total consideration for the

------

Acquisition, the Company has estimated the allocations to such assets and liabilities. This preliminary purchase price allocation has been used to prepare the Transaction Accounting Adjustments in the unaudited pro forma condensed combined balance sheet. The final purchase price allocation will be determined when Phreesia has determined the final consideration and completed the detailed valuations and necessary calculations. The final purchase price allocation could differ materially from the preliminary purchase price allocation used to prepare the Transaction Accounting Adjustments. The final purchase price allocation may include (i) changes in allocations to identifiable intangible assets or goodwill based on the results of certain valuations that have yet to be finalized, (ii) other changes to assets and liabilities, and (iii) assessment of tax positions and tax rates.

For purposes of measuring the estimated fair value of the tangible and identifiable intangible assets acquired and the liabilities assumed, the Company has applied the guidance in Accounting Standards Codification Topic 820, *Fair Value Measurements* ("ASC 820"), which establishes a framework for measuring fair value. ASC 820 defines fair value as "the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."

**Note 2. Significant accounting policies**

The accounting policies used in the preparation of this unaudited pro forma condensed combined financial information are those set out in the Company's audited consolidated financial statements as of and for the year ended January 31, 2025. Adjustments to conform AccessOne's historical financial statements to the Company's accounting policies in the preparation of the unaudited pro forma condensed combined financial information were not significant. This is subject to change as further assessment is performed and finalized for purchase accounting. As part of the application of ASC 805, Phreesia will continue conducting a detailed review of AccessOne's accounting policies to determine if differences in accounting policies require reclassification or adjustment of AccessOne's results of operations, assets or liabilities to conform to the Company's accounting policies and classifications. Therefore, the Company may identify differences between the accounting policies of the two companies that, when conformed, could have a material impact on the unaudited pro forma condensed combined financial information.

**Note 3. Preliminary purchase price allocation**

***Preliminary purchase consideration***

The total preliminary purchase consideration including amounts deposited into escrow is $163.7 million. This includes the base purchase price of $160.0 million, plus estimated adjustments for working capital and closing cash. Escrow deposits totaling $8.6 million were established under the Merger Agreement to cover potential indemnity obligations and post-closing adjustments. The Company does not control the escrow deposits. Accelerated unvested options, retention bonuses, severance, and certain change-of-control payments are contingent on post-closing actions or continued service and are therefore treated as post-closing compensation expense, not consideration under ASC 805 and were not significant. Other change-of-control bonuses totaling $1.4 million were paid pursuant to existing change-of-control agreements not contingent on continued service and were included in purchase consideration.

The purchase price does not include any contingent consideration, earn-outs, or seller notes. The consideration was funded with a combination of cash on hand and the net proceeds from the Bridge Loan. All amounts are preliminary and subject to change pending final closing statements and completion of the Company's valuation procedures.

***Preliminary purchase price allocation***

The Company performed a preliminary valuation analysis of the estimated fair value of the assets acquired and liabilities assumed in connection with the Acquisition. The allocation was prepared in accordance with ASC 805. The following table summarizes the allocation of the preliminary purchase price as of the Closing Date (in thousands):

------

---

| | |
|:---|:---|
| **Assets** | **November 12, 2025** |
| Cash and restricted cash | $10474 |
| Accounts receivable | 708 |
| Cardholder receivables | 42537 |
| Deferred purchase price receivable | 18880 |
| Accrued interest and fees receivable | 394 |
| Prepaid expenses and other current assets | 376 |
| Property and equipment | 256 |
| Operating lease right-of-use assets | 1859 |
| Intangible assets | 66600 |
| Goodwill | 77667 |
| Long-term cardholder receivables | 51989 |
| Long-term deferred purchase price receivable | 5639 |
| Other assets | 207 |
| &nbsp;&nbsp;Total assets acquired | $277586 |
| **Liabilities** |  |
| Current portion of operating lease liabilities | $685 |
| Accounts payable | 652 |
| Accrued expenses | 2375 |
| Current portion of due to health care providers | 41745 |
| Deferred revenue | 20 |
| Other current liabilities | 167 |
| Operating lease liabilities, non-current | 1174 |
| Deferred tax liabilities | 16081 |
| Long-term due to health care providers | 51021 |
| &nbsp;&nbsp;Total liabilities assumed | 113920 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net assets acquired | $163666 |

---

This estimated preliminary purchase price allocation has been used to prepare pro forma adjustments in the unaudited pro forma condensed combined balance sheet and statements of operations. The final purchase price will be completed when the Company has completed the detailed valuations and necessary calculations within the measurement period ending 12 months from the Closing Date. The final allocation could differ materially from the preliminary calculation used in the pro forma adjustments. The final allocation may include (i) changes in allocations to identifiable intangible assets including goodwill, (ii) other changes to assets and liabilities, and (iii) assessment of tax positions and tax rates.

***Intangible assets***

Preliminary identifiable intangible assets in the unaudited pro forma condensed combined financial information consist of the following (in thousands, excluding years):

---

| | | |
|:---|:---|:---|
| **Intangible Assets** | **Approximate Fair Value** | **Estimated Useful Life** |
|  |  | (in years) |
| Customer relationships | $44500 | 7.5 |
| Technology | 15500 | 6.0 |
| Trademark | 6600 | 12.0 |
|  | $66600 |  |

---

------

The amortization expense related to the identifiable intangible assets is reflected as a Transaction Accounting Adjustment within amortization in the unaudited pro forma condensed combined statements of operations based on the estimated useful lives above and as further described in Note 5. The fair values of the identifiable intangible assets are preliminary and are based on management's estimates as of the Closing Date. The preliminary fair value of the identifiable intangible assets was determined using the multi-period excess earnings method and relief from royalty method, under the income approach. The Company applied judgment in estimating the fair value of customer relationships under the multi-period excess earnings method which involved the use of significant assumptions with respect to revenue growth rates, contributory asset charges, asset adjustments and add backs, customer attrition rate, discount rate, and terminal growth rate. The preliminary fair value of the developed technology and trademark was estimated using the relief from royalty method which incorporates assumptions for obsolescence, attrition, royalty rates, tax rate, and discount rate.

The amount that will ultimately be allocated to identifiable intangible assets may differ materially from this preliminary allocation. In addition, the amortization impacts will ultimately be based upon the periods in which the associated economic benefits or detriments are expected to be derived. Therefore, the amount of amortization following the Acquisition may differ significantly between periods based upon the final value and useful life assigned and amortization methodology used for each identifiable intangible asset.

**Note 4. Notes to Unaudited Pro Forma Condensed Combined Balance Sheet**

Transaction Accounting Adjustments include the following adjustments, which are based on the Company's preliminary estimates and assumptions, related to the unaudited pro forma condensed combined balance sheet as of October 31, 2025:

a.Represents preliminary adjustments to reflect the cash outflow for purchase consideration and transaction expenses. These amounts are based on management's best estimates and are subject to change upon finalization of closing statements. See Note 3 for details of the purchase price allocation. The adjustments to cash and restricted cash are summarized as follows (in thousands):

---

| | |
|:---|:---|
| Purchase consideration (Note 3.) | $(163666) |
| Adjustment to fair value on Closing Date (Note 4.b.) | (2218) |
| Adjustment for transaction expenses (Note 5.l.)<sup>(1)</sup> | (6052) |
| Total Transaction Accounting Adjustments | $(171936) |

---

<sup>(1)</sup> Represents the payment of transaction expenses on the Closing Date.

b. Represents fair value adjustments to the opening balance sheet as of the Closing Date. Material adjustments to fair value were recorded in cardholder receivables, deferred purchase price receivable, and amounts due to health care providers. The calculation of fair value is preliminary and subject to change. The fair value of the cardholder receivables, deferred purchase price receivable, and amounts due to health care providers was determined using a discounted cash flow methodology, which incorporates significant assumptions related to contractual terms, expected repayment and settlement timing, and counterparty credit quality.

c. Reflects the recognition of identifiable intangible assets and goodwill as described in Note 3. The adjustments to identifiable intangible assets and goodwill are summarized as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **Intangible Assets** | **Goodwill** |
| Adjustment to remove AccessOne's historical balances | $(172) | $(71964) |
| Adjustment to reflect fair value at Closing Date (Note 4.b.) | 66600 | 77667 |
| &nbsp;&nbsp;Total Transaction Accounting Adjustments | $66428 | $5703 |

---

d. Represents adjustments to remove AccessOne's historical debt obligations including any debt discount not assumed by Phreesia. These obligations were settled at closing and are eliminated from the unaudited pro forma condensed combined balance sheet. The following summarizes the adjustments at the Closing Date (in thousands):

------

---

| | |
|:---|:---|
| Adjustment to reflect liabilities settled at Closing Date | $(35221) |
| Adjustment to reflect fair value at Closing Date (Note 4.b.) | 777 |
| &nbsp;&nbsp;Total Transaction Accounting Adjustments | $(34444) |

---

e. Primarily represents the accrual of $0.8 million of transaction expenses for the Acquisition that were accrued by the Company at closing and paid subsequent to closing and $0.8 million of adjustments to reflect fair value at the Closing Date.

f. Reflects the purchase accounting adjustment to AccessOne's deferred tax liabilities of $16.1 million associated with the acquired intangible assets and the release of a portion of the Company's preexisting deferred tax asset valuation allowance of $13.7 million in the pro forma condensed combined financial information.

g. Reflects the elimination of AccessOne's historical equity balances, recognition of transaction expenses incurred by Phreesia in connection with the Acquisition, and the release of the valuation allowance on the Company's deferred tax assets. Transaction expenses and the valuation allowance release are nonrecurring. The following summarizes the adjustments related to stockholder's equity (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Elimination of Historical AccessOne Equity**<sup>(1)</sup> | **Transaction Expenses**<sup>(2)</sup> | **Valuation Allowance Release**<sup>(3)</sup> | **Total Transaction Accounting Adjustments** |
| Additional paid-in capital | $(68028) | $— | $— | $(68028) |
| Accumulated deficit | 5476 | (6892) | 13656 | 12240 |
| &nbsp;&nbsp;Total | $(62552) | $(6892) | $13656 | $(55788) |

---

<sup>(1)</sup> Represents the elimination of the historical AccessOne equity.

<sup>(2)</sup> These non-recurring transaction expenses are reflected as if they were incurred on October 31, 2025, the date of the Acquisition for purposes of the unaudited pro forma condensed combined balance sheets.

<sup>(3)</sup> Represents the release of a portion of the valuation allowance related to the Company's preexisting deferred tax assets primarily due to the recognition of deferred income tax liabilities associated with the acquired intangible assets. The Company has determined that the deferred tax liabilities related to the Acquisition provide sufficient taxable income to realize a portion of the Company's preexisting deferred tax assets. The income tax benefit adjustment related to the reduction of the valuation allowance is nonrecurring.

Other Transaction Accounting Adjustments include the following, which are based on the Company's preliminary estimates and assumptions, related to the unaudited pro forma condensed combined balance sheet as of October 31, 2025:

i.Reflects the portion of the purchase price for the Acquisition that was funded with net proceeds from the Bridge Loan.

ii. Represents the net proceeds from the Bridge Loan obtained on the Closing Date. The Bridge Loan matures on November 11, 2026 and is classified as a current liability because its contractual term is approximately one year.

**Note 5. Notes to Unaudited Pro Forma Condensed Combined Statements of Operations**

Transaction Accounting Adjustments include the following adjustments, which are based on the Company's preliminary estimates and assumptions, related to the unaudited pro forma condensed combined statements of operations for the nine months ended October 31, 2025 and for the year ended January 31, 2025.

h. Reflects the amortization expense related to finite-lived identifiable intangible assets acquired in connection with the Acquisition based on preliminary fair values and estimated useful lives and the elimination of AccessOne's historical amortization expense. See Note 3. The following table summarizes these adjustments (in thousands):

------

---

| | | |
|:---|:---|:---|
| | **Nine months ended October 31, 2025** | **Year ended January 31, 2025** |
| Adjustment to remove AccessOne's historical amortization expense | $(512) | $(684) |
| Adjustment to reflect Acquisition intangible assets amortization expense | 6800 | 9067 |
| &nbsp;&nbsp;Total Transaction Accounting Adjustments | $6288 | $8383 |

---

i. Reflects the removal of AccessOne's historical interest expense for obligations not assumed by Phreesia on the Closing Date.

j. The following table summarizes the components of the adjustments to income tax (expense) benefit included in the Transaction Accounting Adjustments column of the unaudited pro forma condensed combined statements of operations for the nine months ended October 31, 2025 and the year ended January 31, 2025 (in thousands):

---

| | | |
|:---|:---|:---|
| | **Nine months ended October 31, 2025** | **Year ended January 31, 2025** |
| Valuation allowance release<sup>(1)</sup> | $— | $13656 |
| Adjustments to remove income tax expense recorded in historical periods<sup>(2)</sup> | 1125 | 402 |
| Other income tax adjustments<sup>(3)</sup> | (339) | 474 |
| &nbsp;&nbsp;Total Transaction Accounting Adjustments | $786 | $14532 |

---

<sup>(1)</sup> Represents the release of a portion of the valuation allowance related to the Company's preexisting deferred tax assets primarily due to the recognition of deferred income tax liabilities associated with the acquired intangible assets, which provide sufficient taxable income to realize the Company's preexisting deferred tax assets. The income tax benefit adjustment related to the reduction of the valuation allowance is nonrecurring.

<sup>(2)</sup> Represents the removal of all income tax expense reflected in AccessOne's historical results for the nine months ended October 31, 2025 as well as the removal of total deferred income tax expense and current federal income tax expense reflected in AccessOne's historical results for the year ended January 31, 2025.

<sup>(3)</sup> Other income tax adjustments reflect the state income taxes attributable to AccessOne's historical results for the nine months ended October 31, 2025 together with the state income tax effects associated with the Transaction Accounting Adjustments for the nine months ended October 31, 2025 and the year ended January 31, 2025. There are no expected federal income tax impacts as a result of the Company's history of pre-tax losses.

k. Reflects the adjustment to diluted weighted-average common shares outstanding to match basic weighted-average common shares outstanding. Since the Company was in a pro forma combined net loss position for the nine months ended October 31, 2025, pro forma combined loss per share attributable to common stockholders was the same on a basic and diluted basis.

l. The unaudited pro forma condensed combined financial information also includes transaction expenses incurred by Phreesia in connection with the Acquisition, primarily legal, advisory, and other professional services. These costs are nonrecurring and will not impact the combined results of operations beyond twelve months after the Closing Date. These non-recurring transaction expenses are reflected as if they were incurred on February 1, 2024, the date of the Acquisition for purposes of the unaudited pro forma condensed combined statement of operations. Amounts already recorded in historical results have not been removed.

Other Transaction Accounting Adjustments include the following adjustments, which are based on the Company's preliminary estimates and assumptions, related to the unaudited pro forma condensed combined statements of operations for the nine months ended October 31, 2025 and for the year ended January 31, 2025.

iii. Reflects the interest expense associated with the Bridge Loan used to finance a portion of the purchase price, including amortization of related debt discount. The adjustment to record interest expense assumes the Bridge Loan was obtained on February 1, 2024 and was outstanding for the entire nine months ended October 31, 2025 and year ended January 31, 2025. The interest rate assumed for purposes of preparing this unaudited pro forma condensed combined financial information is 8.0%. This rate approximates the three-month SOFR of

------

4.0% on November 12, 2025, plus the margins specified in the Bridge Loan. The following adjustments have been recorded to interest expense (in thousands):

---

| | | |
|:---|:---|:---|
| | **Nine months ended October 31, 2025** | **Year ended January 31, 2025** |
| Adjustment to reflect estimated Bridge Loan interest expense | $(6600) | $(8800) |
| Adjustment to reflect amortization of Bridge Loan debt discount | (2342) | (3122) |
| &nbsp;&nbsp;Total Other Transaction Accounting Adjustments | $(8942) | $(11922) |

---

A 1/8 of a percentage point increase or decrease in the benchmark rate would not result in a significant change in interest expense for the nine months ended October 31, 2025 and year ended January 31, 2025.

iv. Other Transaction Accounting Adjustments do not reflect income tax effects related to the interest expense associated with the Bridge Loan due to the application of interest limitation rules and the existence of a full valuation allowance on federal interest carryforwards. In addition, the impact on current state income taxes is not material.

<br>